https://curecurrent.com/trials/efficacy-of-srt-as-salvage-therapy-in-patients-with-brain-oligo-progression-of-egfr-mutant-non-small-cell-lung-cancer-af-48001https://curecurrent.com/trials/safety-and-long-term-effects-of-covid-19-vaccines-in-patients-with-pulmonary-tumor-48002https://curecurrent.com/trials/study-cb-839-in-combination-with-nivolumab-in-patients-with-melanoma-clear-cell-renal-cell-carcinoma-ccrcc-and-non-small-48003https://curecurrent.com/trials/to-explore-the-protective-effect-of-sars-cov-2-vaccination-on-cancer-patients-infected-with-sars-cov-2-48004https://curecurrent.com/trials/mrd-guided-adjuvant-tislelizumab-and-chemotherapy-in-resected-stage-iia-iiib-nsclc-48005https://curecurrent.com/trials/first-line-osimertinib-for-egfr-mutation-positive-non-small-cell-lung-cancer-in-real-world-chinese-setting-48006https://curecurrent.com/trials/assessing-an-oral-egfr-inhibitor-yk-209a-in-patients-who-have-advanced-non-small-cell-lung-cancer-with-egfr-48007https://curecurrent.com/trials/the-incidence-of-pulmonary-embolism-during-nephrectomy-48008https://curecurrent.com/trials/dynamic-evolution-of-pulmonary-nodules-and-influence-factors-of-its-clinical-decision-making-48009https://curecurrent.com/trials/changing-over-time-of-ascorbic-acid-after-chemotherapy-48010https://curecurrent.com/trials/collecting-and-studying-tissue-samples-from-patients-with-hiv-associated-malignancies-48011https://curecurrent.com/trials/effects-of-protein-on-muscle-gut-microbiota-and-clinical-outcome-in-patients-with-lung-cancer-related-sarcopenia-48012https://curecurrent.com/trials/effect-of-compound-amino-acid-tablets-on-nutritional-status-of-patients-with-lung-cancer-48013https://curecurrent.com/trials/diadem-to-investigate-the-activity-and-safety-of-durvalumab-48014https://curecurrent.com/trials/prospective-primary-human-lungcancer-organoids-to-predict-treatment-response-48015https://curecurrent.com/trials/a-study-of-atezolizumab-mpdl3280a-compared-with-a-platinum-agent-cisplatin-or-carboplatin-pemetrexed-or-gemcitabine-in-p-48016https://curecurrent.com/trials/prospective-study-to-determine-impact-of-early-palliative-care-consult-on-quality-of-life-qol-cancer-related-symptoms-in-48017https://curecurrent.com/trials/bicr-in-new-therapeutic-lung-cancer-trials-48018https://curecurrent.com/trials/immune-neoadjuvant-therapy-study-of-durvalumab-in-early-stage-non-small-cell-lung-cancer-48019https://curecurrent.com/trials/maintenance-after-induction-chemotherapy-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-48020https://curecurrent.com/trials/95-effective-dose-ed95-of-remimazolam-during-dexmedetomidine-pretreatment-48021https://curecurrent.com/trials/paclitaxel-bevacizumab-in-advanced-lung-cancer-48022https://curecurrent.com/trials/chemotherapy-for-lung-cancer-in-hiv-positive-patients-48023https://curecurrent.com/trials/improving-sleep-in-lung-cancer-patients-a-trial-of-aerobic-exercise-and-tai-chi-48024https://curecurrent.com/trials/study-to-evaluate-na-nose-for-monitoring-and-detecting-recurrence-in-early-stage-lung-cancer-48025https://curecurrent.com/trials/a-study-of-the-safety-of-atezolizumab-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-in-48026https://curecurrent.com/trials/re-introduction-of-pemetrexed-and-cisplatin-with-prolonged-angiogenic-blocking-by-bevacizumab-in-advanced-lung-cancer-48027https://curecurrent.com/trials/ngs-screening-protocol-to-detect-mutation-of-keap1-or-nrf2-nfe2l2-genes-for-the-keapsake-cx-839-014-trial-48028https://curecurrent.com/trials/bempegaldesleukin-and-pembrolizumab-with-or-without-chemotherapy-in-locally-advanced-or-metastatic-solid-tumors-48029https://curecurrent.com/trials/cpi-613-devimistat-in-combination-with-hydroxychloroquine-and-5-fluorouracil-or-gemcitabine-in-treating-patients-with-ad-48030https://curecurrent.com/trials/liquik-liquid-biopsy-for-detection-of-actionable-genomic-biomarkers-in-patients-with-advanced-non-small-cell-lung-cancer-48031https://curecurrent.com/trials/durvalumab-in-combination-with-standard-chemotherapy-of-patients-with-extensive-stage-small-cell-lung-cancer-48032https://curecurrent.com/trials/prospective-evaluation-of-immunological-molecular-genetic-image-based-and-microbial-analyzes-to-characterize-tumor-respo-48033https://curecurrent.com/trials/intrapleural-instillation-of-the-nivolumab-in-cancer-patients-with-pleural-effusion-48034https://curecurrent.com/trials/osimertinib-as-1st-line-therapy-for-patients-with-advanced-egfr-positive-non-small-cell-lung-cancer-48035https://curecurrent.com/trials/a-phase-ii-trial-measuring-the-integration-of-stereotactic-radiotherapy-plus-surgery-in-early-non-small-cell-lung-cancer-48036https://curecurrent.com/trials/screening-of-tobacco-induced-cancers-by-low-dose-ct-scanner-and-identification-of-circulating-tumor-cells-48037https://curecurrent.com/trials/cognitive-behavioral-therapy-cbt-insomnia-for-lung-cancer-48038https://curecurrent.com/trials/phase-1-1b-study-of-mgcd516-in-patients-with-advanced-cancer-48039https://curecurrent.com/trials/microbial-colonization-in-lung-cancer-patients-48040https://curecurrent.com/trials/preschool-wheeze-inflammation-infection-guided-management-48041https://curecurrent.com/trials/immunotherapy-sbrt-sensitization-of-the-programmed-death-1-pd-1-effect-48042https://curecurrent.com/trials/study-of-pasireotide-long-acting-release-lar-in-patients-with-metastatic-neuroendocrine-tumors-nets-48043https://curecurrent.com/trials/clinical-study-of-ametinib-combined-with-bevacizumab-in-first-line-treatment-of-advanced-nsclc-with-egfr-mutations-48044https://curecurrent.com/trials/camrelizumab-combined-with-albumin-bound-paclitaxel-and-platinum-in-neoadjuvant-treatment-of-resectable-nsclc-48045https://curecurrent.com/trials/bevacizumab-after-chemoradiotherapy-for-locally-advanced-lung-adenocarcinoma-48046https://curecurrent.com/trials/tipifarnib-and-osimertinib-in-egfr-mutated-non-small-cell-lung-cancer-48047https://curecurrent.com/trials/a-multicenter-phase-ii-study-of-stereotactic-radiotherapy-for-centrally-located-lung-tumors-strict-lung-study-and-ultra-48048https://curecurrent.com/trials/analysis-of-soluble-mediators-cytokines-and-facs-as-prognostic-factors-in-advanced-non-squamous-lung-carcinoma-48049https://curecurrent.com/trials/a-retrospective-multicenter-review-to-evaluate-the-performance-of-the-ion-endoluminal-system-in-sampling-pulmonary-lesio-48050https://curecurrent.com/trials/in-vivo-investigation-on-mitochondrial-dysfunction-in-post-covid-fatigue-and-cancer-fatigue-48051https://curecurrent.com/trials/kn046-in-patients-with-advanced-non-small-cell-lung-cancer-48052https://curecurrent.com/trials/an-open-label-randomized-phase-3-trial-of-nivolumab-versus-investigator-s-choice-chemotherapy-as-first-line-therapy-for-48053https://curecurrent.com/trials/nitrous-oxide-for-identifying-the-intersegmental-plane-in-segmentectomy-a-randomized-controlled-trial-48054https://curecurrent.com/trials/srs-timing-with-immune-checkpoint-inhibition-in-patients-with-untreated-brain-metastases-from-non-small-cell-lung-cancer-48055https://curecurrent.com/trials/nivolumab-and-ipilimumab-versus-chimiotherapy-in-first-line-treatment-in-ps-2-or-elderly-in-advanced-nsclc-patients-48056https://curecurrent.com/trials/resilience-and-coping-in-a-rare-skeletal-disease-population-to-face-coronavirus-covid-19-outbreak-distress-a-longitudina-48057https://curecurrent.com/trials/ebus-miniforceps-biopsy-specimen-acquisition-for-pd-l1-testing-in-nonsmall-cell-lung-cancer-48058https://curecurrent.com/trials/carboplatin-plus-pemetrexed-plus-atezolizumab-plus-bevacizumab-in-chemotherapy-and-immunotherapy-na-ve-patients-with-sta-48059https://curecurrent.com/trials/sbrt-and-art-for-pulmonary-metastases-from-soft-tissue-sarcomas-48060https://curecurrent.com/trials/effect-of-genetic-and-epigenetic-factors-on-the-clinical-response-and-toxicity-to-cisplatin-among-egyptian-non-small-cel-48061https://curecurrent.com/trials/sintilimab-in-combination-with-gemcitabine-and-platinum-based-chemotherapy-as-first-line-therapy-for-advanced-or-metasta-48062https://curecurrent.com/trials/a-chart-review-study-of-adults-with-advanced-nsclc-48063https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-between-ibi308-and-docetaxel-in-patients-with-advanced-or-metastatic-nsclc-48064https://curecurrent.com/trials/a-pk-similarity-study-of-two-sintilimab-products-produced-by-different-processes-in-advanced-or-metastatic-nsclc-patient-48065https://curecurrent.com/trials/clinico-immunological-characterization-and-immune-tolerance-breakdown-in-hu-autoimmunity-48066https://curecurrent.com/trials/effect-of-sleep-disorder-on-the-development-of-lung-tumors-48067https://curecurrent.com/trials/implementing-a-tool-to-identify-risk-for-venous-thromboembolism-in-cancer-patients-48068https://curecurrent.com/trials/oncology-research-information-exchange-network-orien-lung-cancer-study-48069https://curecurrent.com/trials/a-phase-ib-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-ibi318-in-combination-with-paclitaxel-versus-placeb-48070https://curecurrent.com/trials/a-study-evaluating-the-drug-levels-of-iplimumab-given-under-the-skin-alone-and-in-combination-with-nivolumab-in-multiple-48071https://curecurrent.com/trials/geriatric-and-quality-of-life-assessments-in-older-patients-with-non-metastatic-or-metastatic-head-and-neck-or-lung-canc-48072https://curecurrent.com/trials/a-study-of-adxs-neo-expressing-personalized-tumor-antigens-48073https://curecurrent.com/trials/a-phase-ii-study-of-rulonilimab-combined-with-chemotherapy-in-the-first-line-treatment-for-advanced-or-metastatic-non-sm-48074https://curecurrent.com/trials/ibi310-anti-ctla-4-in-combination-with-sintilimab-in-patients-with-non-small-cell-lung-cancer-nsclc-48075https://curecurrent.com/trials/oxycodone-in-combination-with-parathoracic-nerve-block-is-used-for-postoperative-analgesia-in-lung-cancer-48076https://curecurrent.com/trials/analysis-of-risk-factors-of-postoperative-pulmonary-infection-in-patients-with-esophageal-cancer-48077https://curecurrent.com/trials/hyperpolarized-xenon-gas-mr-imaging-in-nsclc-radiotherapy-48078https://curecurrent.com/trials/s1-plus-anlotinib-in-treating-patients-with-refractory-or-relapsed-small-cell-lung-cancer-48079https://curecurrent.com/trials/coorticosteroid-regimen-in-patients-with-anti-pd-1-pd-l1-induced-pneumonitis-48080https://curecurrent.com/trials/engaging-patients-in-colon-cancer-screening-decisions-during-covid-19-48081https://curecurrent.com/trials/adebrelimab-combined-with-bevacizumab-and-albumin-paclitaxel-in-non-squamous-nsclc-after-first-line-treatment-48082https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-abtl0812-48083https://curecurrent.com/trials/best-egfr-tki-sequence-in-nsclc-harboring-egfr-mutations-48084https://curecurrent.com/trials/deep-learning-signature-for-predicting-the-novel-grading-system-of-clinical-stage-i-lung-adenocarcinoma-48085https://curecurrent.com/trials/osimertinib-combined-with-anlotinib-in-egfr-t790m-mutated-nsclc-patients-with-progression-on-osimertinib-treatment-48086https://curecurrent.com/trials/177lu-dotatoc-for-the-treatment-of-patients-with-somatostatin-receptor-positive-nets-48087https://curecurrent.com/trials/predicting-responsiveness-in-oncology-patients-based-on-host-response-evaluation-during-anti-cancer-treatments-using-mul-48088https://curecurrent.com/trials/circulating-tumor-dna-and-t-cell-repertoire-predict-radiotherapeutic-outcomes-in-nsclc-patients-with-brain-metastasis-48089https://curecurrent.com/trials/local-ablative-stereotactic-radiotherapy-for-residual-hypermetabolic-lesion-in-patients-with-locally-advanced-or-metasta-48090https://curecurrent.com/trials/xzp-5809-tt1-tablets-in-patients-with-t790m-mutation-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer-48091https://curecurrent.com/trials/glucobrassicin-brussel-sprout-effect-on-d10-phe-metabolism-48092https://curecurrent.com/trials/the-effect-of-dexmedetomidine-on-oxygen-during-one-lung-ventilation-in-pediatric-surgery-48093https://curecurrent.com/trials/microbiome-immunotherapy-toxicity-and-response-evaluation-48094https://curecurrent.com/trials/a-study-to-evaluate-shr-1210-in-patients-with-advanced-or-metastatic-nsclc-48095https://curecurrent.com/trials/bronchoscopic-laser-ablation-of-peripheral-lung-tumors-48096https://curecurrent.com/trials/adjuvant-furmonertinib-in-stage-ia-with-high-risk-factors-and-stage-ib-non-small-cell-lung-cancer-48097https://curecurrent.com/trials/real-world-observational-study-of-pembrolizumab-for-chinese-advanced-nsclc-48098https://curecurrent.com/trials/yoga-program-for-lung-cancer-patients-and-caregivers-48099https://curecurrent.com/trials/patient-skin-dose-in-interventional-radiology-48100https://curecurrent.com/trials/radiation-and-chemotherapy-with-ipilimumab-followed-by-nivolumab-for-patients-with-stage-iii-unresectable-non-small-cell-48101https://curecurrent.com/trials/18f-fdg-pet-ct-to-evaluate-pd-1-monoclonal-antibody-with-first-line-chemotherapy-in-advanced-nsclc-48102https://curecurrent.com/trials/nivolumab-in-patients-with-advanced-non-small-cell-lung-cancer-and-pre-existing-autoimmune-disease-48103https://curecurrent.com/trials/pre-operative-inspiratory-muscle-training-program-to-prevent-pulmonary-complications-after-thoracic-surgery-48104https://curecurrent.com/trials/pembrolizumab-vs-topotecan-in-patients-with-small-cell-lung-cancer-48105https://curecurrent.com/trials/mek-inhibitor-and-thoracic-radiotherapy-trial-48106https://curecurrent.com/trials/tqb2450-injection-combined-with-chemotherapy-followed-by-sequential-combination-with-anlotinib-hydrochloride-capsule-for-48107https://curecurrent.com/trials/study-of-hs-10241-in-combination-with-almonertinib-in-patients-with-locally-advanced-or-metastatic-nsclc-48108https://curecurrent.com/trials/phase-i-ii-study-of-sy-3505-in-patients-with-alk-positive-advanced-non-small-cell-lung-cancer-48109https://curecurrent.com/trials/evaluation-of-preoperative-acceptance-of-proactive-palliative-care-intervention-48110https://curecurrent.com/trials/a-dose-frequency-optimization-trial-of-nivolumab-240-mg-every-2-weeks-vs-nivolumab-480-mg-every-4-weeks-in-subjects-with-48111https://curecurrent.com/trials/nefopam-as-a-multimodal-analgesia-for-thoracic-surgery-48112https://curecurrent.com/trials/a-prevention-trial-of-canakinumab-in-subjects-at-high-risk-for-lung-cancer-48113https://curecurrent.com/trials/pd-l1-pet-imaging-in-patients-with-the-immunotherapy-for-non-small-cell-lung-cancer-48114https://curecurrent.com/trials/prediction-model-of-icis-combined-with-chemotherapy-in-advanced-nsclc-48115https://curecurrent.com/trials/br790-in-combination-with-anlotinib-in-adult-subjects-with-advanced-non-small-cell-lung-cancer-48116https://curecurrent.com/trials/impact-of-covid-19-pandemic-on-management-of-head-and-neck-cancers-48117https://curecurrent.com/trials/deep-learning-signature-for-predicting-occult-nodal-metastasis-of-clinical-n0-lung-cancer-48118https://curecurrent.com/trials/study-of-bms-936558-nivolumab-compared-to-docetaxel-in-previously-treated-metastatic-non-squamous-nsclc-48119https://curecurrent.com/trials/study-of-protmune-for-allogeneic-hct-in-adult-patients-with-hematologic-malignancies-48120https://curecurrent.com/trials/evaluation-of-contextflow-detect-lung-ct-nodule-detection-software-in-chest-ct-scans-48121https://curecurrent.com/trials/efikronik-research-program-physical-exercise-for-people-with-chronic-pathologies-48122https://curecurrent.com/trials/ds-1205c-with-gefitinib-for-metastatic-or-unresectable-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lung-48123https://curecurrent.com/trials/evaluation-of-blood-tmb-for-the-efficacy-of-atezolizumab-buddy-48124https://curecurrent.com/trials/a-study-of-oral-pf-02341066-a-c-met-hepatocyte-growth-factor-tyrosine-kinase-inhibitor-in-patients-with-advanced-cancer-48125https://curecurrent.com/trials/d-lung-an-analytics-platform-for-lung-cancer-based-on-deep-learning-technology-48126https://curecurrent.com/trials/impact-of-lazertinib-dose-modification-on-effectiveness-and-safety-48127https://curecurrent.com/trials/limonene-for-pulmonary-nodule-chemoprevention-48128https://curecurrent.com/trials/predictive-gene-profiles-and-dynamic-measurement-of-treatment-response-in-metastatic-non-small-cell-lung-cancer-48129https://curecurrent.com/trials/study-of-the-humoral-response-to-sars-cov-2-variants-and-of-the-cellular-response-after-vaccination-against-covid-19-in-48130https://curecurrent.com/trials/the-study-of-high-protein-nutritional-support-impact-on-postoperative-outcomes-in-patients-with-primary-lung-cancer-48131https://curecurrent.com/trials/ceritinib-in-combination-with-stereotactic-ablative-radiation-metastatic-lung-adenocarcinoma-48132https://curecurrent.com/trials/predicting-response-to-pd-1-checkpoint-blockade-using-deep-learning-analysis-of-imaging-and-clinical-data-48133https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-toripalimab-or-placebo-combined-with-chemotherapy-in-treatment-naive-adva-48134https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-vb-201-in-patients-with-covid-19-48135https://curecurrent.com/trials/lung-cancer-diagnosis-by-detecting-epigenetic-imprinting-alterations-in-bronchoalveolar-lavage-48136https://curecurrent.com/trials/cost-effectiveness-evaluation-of-robotic-surgery-in-the-removal-of-lung-lesions-in-the-ats-of-milan-48137https://curecurrent.com/trials/mil60-versus-bevacizumab-in-patients-with-treatment-na-ve-non-squamous-non-small-cell-lung-cancer-48138https://curecurrent.com/trials/perioperative-cognitive-training-in-thoracic-surgery-48139https://curecurrent.com/trials/fasting-like-approach-and-maintenance-immunotherapy-in-es-sclc-patients-not-progressing-on-chemoimmunotherapy-induction-48140https://curecurrent.com/trials/evaluation-of-the-novatech-luciola-tm-eb-fiducial-marker-during-radiotherapy-sessions-in-lung-cancer-patients-48141https://curecurrent.com/trials/open-label-pet-study-with-11c-osimertinib-in-patients-with-egfrm-nsclc-and-brain-metastases-48142https://curecurrent.com/trials/a-phase-1-drug-drug-interaction-study-between-brigatinib-and-the-cyp3a-substrate-midazolam-in-participants-with-alk-posi-48143https://curecurrent.com/trials/lazertinib-160mg-in-egfr-t790m-nsclc-48144https://curecurrent.com/trials/evaluation-of-the-reproducibility-of-ablation-volumes-at-one-month-after-microwave-treatment-compared-to-the-manufacture-48145https://curecurrent.com/trials/a-pilot-study-to-understand-the-impact-of-therapy-with-tumour-treating-fields-ttfields-in-nsclc-48146https://curecurrent.com/trials/trial-of-brigatinib-after-treatment-with-next-generation-alk-inhibitors-48147https://curecurrent.com/trials/certolizumab-in-combination-with-chemotherapy-for-patients-with-stage-iv-lung-adenocarcinomas-48148https://curecurrent.com/trials/registry-of-patients-with-hematologic-disease-and-covid-19-in-russia-48149https://curecurrent.com/trials/serum-derived-bovine-immunoglobulin-effect-on-mucositis-48150https://curecurrent.com/trials/selinexor-treatment-of-advanced-relapsed-refractory-squamous-cell-carcinomas-48151https://curecurrent.com/trials/main-postoperative-complications-after-covid-19-48152https://curecurrent.com/trials/identification-of-predictive-and-prognostic-markers-for-lung-cancer-with-metastases-48153https://curecurrent.com/trials/a-study-to-evaluate-safety-pk-and-efficacy-of-hs-10296-in-patients-with-nsclc-48154https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-hs-10296-as-first-line-treatment-in-patients-48155https://curecurrent.com/trials/radiation-pneumonitis-after-sbrt-for-nsclc-48156https://curecurrent.com/trials/airway-remodeling-during-mepolizumab-treatment-48157https://curecurrent.com/trials/safety-and-efficacy-study-of-amg-820-and-pembrolizumab-combination-in-select-advanced-solid-tumor-cancer-48158https://curecurrent.com/trials/a-phase-i-ib-trial-of-mek162-in-combination-with-erlotinib-in-nsclc-harboring-kras-or-egfr-mutation-48159https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-sub-s-48160https://curecurrent.com/trials/mira-clinical-learning-environment-miracle-lung-48161https://curecurrent.com/trials/ebus-miniprobes-sampling-for-peripheral-lung-lesions-48162https://curecurrent.com/trials/bioimaging-study-of-89zr-m7824-in-nsclc-48163https://curecurrent.com/trials/osimertinib-therapy-after-resection-in-high-risk-stage-i-egfrm-nsclc-ostar-48164https://curecurrent.com/trials/pet-mr-imaging-in-lung-cancer-48165https://curecurrent.com/trials/clinical-study-of-pan-cancer-dna-methylation-test-in-plasma-48166https://curecurrent.com/trials/study-for-treatment-with-th-4000-tarloxotinib-in-epidermal-growth-factor-receptor-egfr-mutant-t790m-negative-non-small-c-48167https://curecurrent.com/trials/patient-portal-and-navigation-program-in-providing-information-for-asian-american-cancer-patients-48168https://curecurrent.com/trials/exparel-and-marcaine-for-pain-management-in-thoracoscopic-lobectomy-patients-48169https://curecurrent.com/trials/clinical-study-of-utidelone-injection-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-48170https://curecurrent.com/trials/enb-guided-mwa-combined-with-vats-versus-sequential-surgery-for-synchronous-bilateral-multiple-primary-lung-nodules-48171https://curecurrent.com/trials/prevalence-and-malignant-involvement-of-calcified-intrathoracic-lymph-nodes-in-patients-undergoing-endosonography-48172https://curecurrent.com/trials/protein-intake-in-patients-with-colorectal-or-lung-cancer-when-receiving-a-nutritional-supplement-48173https://curecurrent.com/trials/development-and-validation-of-nomogram-predicting-survival-in-chinese-sclc-patients-48174https://curecurrent.com/trials/a-study-of-atezolizumab-compared-with-docetaxel-in-non-small-cell-lung-cancer-nsclc-after-failure-with-platinum-containi-48175https://curecurrent.com/trials/prevalence-of-egfr-mutations-in-epidermo-d-bronchopulmonary-cancers-in-r-union-island-48176https://curecurrent.com/trials/tils-low-dose-il-2-therapy-following-cyclophosphamide-and-fludarabine-in-pleural-mesothelioma-patients-48177https://curecurrent.com/trials/hsi-for-intersegmental-plane-identification-during-sublobar-pulmonary-resections-48178https://curecurrent.com/trials/molecular-signature-from-tumor-to-lymph-nodes-48179https://curecurrent.com/trials/serplulimab-combined-with-anti-vegf-antibody-in-advanced-lung-adenocarcinoma-48180https://curecurrent.com/trials/thoracoscopic-laser-speckle-contrast-imaging-for-segment-resections-48181https://curecurrent.com/trials/role-of-intrapulmonary-lymph-nodes-in-patients-with-nsclc-and-visceral-pleural-invasion-48182https://curecurrent.com/trials/real-world-assessment-of-clinical-outcomes-in-metastatic-nsclc-patients-with-met-exon-14-skipping-mutation-and-brain-met-48183https://curecurrent.com/trials/rw-effectiveness-of-capmatinib-in-advanced-met-dysregulated-nsclc-included-in-the-french-compassionate-use-program-atu-48184https://curecurrent.com/trials/furmonertinib-combined-with-anlotinib-as-the-first-line-treatment-in-patients-with-egfr-mutation-positive-nsclc-48185https://curecurrent.com/trials/rw-effectiveness-of-lurbinectedin-in-extensive-stage-sclc-48186https://curecurrent.com/trials/i3lung-integrative-science-intelligent-data-platform-for-individualized-lung-cancer-care-with-immunotherapy-48187https://curecurrent.com/trials/anetumab-ravtansine-and-atezolizumab-in-treating-participants-with-advanced-non-small-cell-lung-cancer-48188https://curecurrent.com/trials/a-study-of-bevacizumab-in-combination-with-first-or-second-line-therapy-in-subjects-with-treated-brain-metastases-due-to-48189https://curecurrent.com/trials/braf-v600-mutated-lung-carcinoma-treated-with-the-combination-of-dabrafenib-trametinib-a-retrospective-evaluation-48190https://curecurrent.com/trials/an-investigational-immuno-therapy-study-of-nivolumab-or-nivolumab-in-combination-with-ipilimumab-or-placebo-in-patients-48191https://curecurrent.com/trials/us-guided-serratus-anterior-plane-block-versus-thoracic-epidural-in-patients-undergoing-thoracotomy-48192https://curecurrent.com/trials/surufatinib-in-combination-of-durvalumab-and-ep-ec-in-the-firstly-line-treatment-of-es-sclc-48193https://curecurrent.com/trials/diaphragmatic-thickness-and-functional-exercise-capacity-in-lobectomy-surgeries-with-thoracotomy-and-vats-48194https://curecurrent.com/trials/hfno-improves-blood-oxygen-saturation-during-asphyxia-during-pulmonary-surgery-with-double-lumen-endotracheal-intubation-48195https://curecurrent.com/trials/comparing-the-impact-of-multimodal-prehabilitation-to-aerobic-training-on-patients-undergoing-thoracoscopic-lobectomy-48196https://curecurrent.com/trials/optimal-sequencing-of-pembrolizumab-mk-3475-and-standard-platinum-based-chemotherapy-in-first-line-nsclc-48197https://curecurrent.com/trials/study-of-bms-936558-nivolumab-compared-to-docetaxel-in-previously-treated-advanced-or-metastatic-squamous-cell-non-small-48198https://curecurrent.com/trials/ceritinib-trametinib-in-patients-with-advanced-alk-positive-non-small-cell-lung-cancer-nsclc-48199https://curecurrent.com/trials/almonertinib-therapy-in-patients-with-abnormal-liver-function-after-egfr-tki-treatment-or-almonertinib-first-line-therap-48200https://curecurrent.com/trials/neoadjuvant-afatinib-therapy-for-potentially-resectable-stage-iii-egfr-mutation-positive-lung-adenocarcinoma-48201https://curecurrent.com/trials/phase-clinical-study-of-tumor-treating-fields-efe-p100-combined-with-docetaxel-in-the-treatment-of-stage-iv-non-small-ce-48202https://curecurrent.com/trials/meals-on-wheels-the-effect-of-a-home-food-delivery-service-for-cancer-patients-48203https://curecurrent.com/trials/analysis-of-the-microenvironment-of-lung-cancer-and-exploration-of-the-mechanism-of-resistance-to-immunotherapy-48204https://curecurrent.com/trials/itil-168-in-advanced-solid-tumors-48205https://curecurrent.com/trials/evaluation-of-vascular-toxicity-of-immune-checkpoint-inhibitors-in-patients-head-and-neck-or-lung-cancer-48206https://curecurrent.com/trials/neoadjuvant-chemoradiation-plus-pembrolizumab-followed-by-consolidation-pembrolizumab-in-nsclc-48207https://curecurrent.com/trials/effects-of-msc-intervention-on-the-dyadic-mental-health-of-lung-cancer-patients-and-their-caregivers-48208https://curecurrent.com/trials/pd-l1-expression-in-cancer-pecan-study-48209https://curecurrent.com/trials/milciclib-in-combination-with-gemcitabine-in-advanced-nsclc-48210https://curecurrent.com/trials/a-real-world-study-of-toripalimab-in-chinese-patients-with-lung-cancer-thunder-study-48211https://curecurrent.com/trials/s1013-validation-of-cancer-questionnaire-for-skin-toxicities-in-patients-with-colorectal-cancer-or-lung-cancer-receiving-48212https://curecurrent.com/trials/neoadjuvant-therapy-of-sintilimab-combined-with-chemotherapy-for-resectable-squamous-cell-nsclc-neoscore-48213https://curecurrent.com/trials/first-line-treatment-for-advanced-non-squamous-non-small-cell-lung-cancer-with-negative-driver-gene-a-single-center-sing-48214https://curecurrent.com/trials/study-to-determine-therapeutic-massage-dosing-to-improve-quality-of-life-in-hospitalized-patients-receiving-palliative-c-48215https://curecurrent.com/trials/liquid-biopsy-in-advanced-oligometastatic-nsclc-receiving-surgery-48216https://curecurrent.com/trials/a-study-of-avastin-in-combination-with-chemotherapy-for-treatment-of-colorectal-cancer-and-non-small-cell-lung-cancer-ar-48217https://curecurrent.com/trials/molecular-profiling-and-dynamic-changes-of-ctdna-in-unresectable-locally-advanced-nsclc-48218https://curecurrent.com/trials/hydroxychloroquine-combined-with-gemcitabine-in-the-treatment-of-advanced-non-small-cell-lung-cancer-48219https://curecurrent.com/trials/physical-stabilization-in-post-vats-48220https://curecurrent.com/trials/excretion-of-acetylamantadine-aa-by-lung-cancer-patients-during-a-chemotherapy-regimen-48221https://curecurrent.com/trials/imaging-tumor-infiltrating-t-cells-in-non-small-cell-lung-cancer-48222https://curecurrent.com/trials/consolidation-conventional-radiotherapy-stereotactic-body-radiotherapy-at-3-months-after-first-line-chemotherapy-in-stag-48223https://curecurrent.com/trials/this-scr-103-protocol-will-permit-sites-to-proactively-assess-taa-hla-and-hpv-16-status-in-patients-with-selected-solid-48224https://curecurrent.com/trials/evaluation-of-a-ddpcr-technology-for-the-sars-cov-2-detection-in-symptomatic-patients-with-suspicion-of-covid-19-48225https://curecurrent.com/trials/radiotherapy-combined-with-pd-1-inhibitors-and-chemotherapy-in-the-treatment-of-nsclc-patients-with-symptomatic-brain-me-48226https://curecurrent.com/trials/evaluation-of-lung-cancer-ct-screening-performance-among-former-and-current-smokers-48227https://curecurrent.com/trials/phase-ii-umbrella-study-directed-by-next-generation-sequencing-48228https://curecurrent.com/trials/safety-study-of-nivolumab-to-treat-advanced-or-metastatic-non-small-cell-lung-cancer-48229https://curecurrent.com/trials/pathological-tumor-and-lymph-node-responses-after-neoadjuvant-immunochemotherapy-in-initially-unresectable-nsclc-48230https://curecurrent.com/trials/carboplatin-and-paclitaxel-with-or-without-isis-3521-in-treating-patients-with-non-small-cell-lung-cancer-48231https://curecurrent.com/trials/clinical-study-of-camrelizumab-combined-with-apatinib-and-albumin-paclitacxel-in-patients-with-advanced-lung-adenocarcin-48232https://curecurrent.com/trials/methylprednisolone-after-split-course-chemoradiotherapy-for-bulky-local-advanced-none-small-cell-lung-cancer-48233https://curecurrent.com/trials/drug-drug-interaction-study-beteewn-ask120067-and-rifampicin-or-itraconazole-48234https://curecurrent.com/trials/anemia-treatment-for-advanced-non-small-cell-lung-cancer-nsclc-patients-receiving-chemotherapy-48235https://curecurrent.com/trials/surufatinib-combined-with-irinotecan-as-a-second-line-treatment-for-small-cell-lung-cancer-48236https://curecurrent.com/trials/a-study-of-morab-202-herein-referred-to-as-farletuzumab-ecteribulin-in-participants-with-solid-tumors-48237https://curecurrent.com/trials/evaluate-safety-tolerability-pharmacokinetics-and-anti-tumor-activity-of-azd3759-48238https://curecurrent.com/trials/molecular-monitoring-of-cfdna-by-ddpcr-in-non-small-cell-lung-cancer-treated-by-immunotherapy-48239https://curecurrent.com/trials/a-study-of-ly3214996-administered-alone-or-in-combination-with-other-agents-in-participants-with-advanced-metastatic-can-48240https://curecurrent.com/trials/modulation-of-autophagy-in-patients-with-advanced-recurrent-non-small-cell-lung-cancer-phase-ii-48241https://curecurrent.com/trials/comprehensive-care-program-for-their-return-to-normal-life-among-lung-cancer-survivors-48242https://curecurrent.com/trials/evaluating-efficacy-and-safety-of-anlotinib-combined-with-concurrent-chemoradiotherapy-followed-by-consolidation-immunot-48243https://curecurrent.com/trials/treatment-registry-of-alectinib-in-anaplastic-lymphoma-kinase-alk-positive-locally-advanced-or-metastatic-non-small-cell-48244https://curecurrent.com/trials/web-based-symptom-monitoring-and-survival-in-advanced-stage-lung-cancer-48245https://curecurrent.com/trials/metronomic-chemotherapy-based-on-adaptative-bio-mathematical-model-of-oral-vinorelbine-in-patients-with-nsclc-or-mpm-48246https://curecurrent.com/trials/clinical-significance-of-circulating-tumour-cells-in-resectable-lung-cancer-patients-48247https://curecurrent.com/trials/prophylaxis-of-venous-thromboembolism-in-advanced-lung-cancer-prove-48248https://curecurrent.com/trials/a-trial-of-camrelizumab-combined-with-famitinib-malate-in-treatment-na-ve-subjects-with-pd-l1-positive-recurrent-or-meta-48249https://curecurrent.com/trials/nutrition-and-pharmacological-algorithm-for-oncology-patients-study-48250https://curecurrent.com/trials/regn2810-anti-pd-1-antibody-platinum-based-doublet-chemotherapy-and-ipilimumab-anti-ctla-4-antibody-versus-pembrolizumab-48251https://curecurrent.com/trials/self-reported-outcomes-of-patients-in-eras-nursing-48252https://curecurrent.com/trials/lung-surgery-with-enhanced-recovery-vs-lung-surgery-without-enhanced-recovery-48253https://curecurrent.com/trials/rct-of-uniport-vats-for-lung-cancer-48254https://curecurrent.com/trials/camrelizumab-with-ac-in-patients-with-brain-metastases-of-driven-gene-negative-nsclc-48255https://curecurrent.com/trials/use-of-dual-energy-computed-tomography-in-thoracic-radiotherapy-planning-48256https://curecurrent.com/trials/clinical-description-of-a-bronchoscopic-approach-to-ablate-lung-nodules-using-the-emprint-ablation-catheter-48257https://curecurrent.com/trials/a-combination-therapy-including-anti-pd-1-immunotherapy-in-rectal-cancer-with-refractory-distal-metastasis-48258https://curecurrent.com/trials/construction-of-microfluidic-exosome-chip-for-diagnosis-of-lung-metastasis-of-osteosarcoma-48259https://curecurrent.com/trials/surufatinib-combined-with-chemotherapy-plus-toripalimab-or-not-in-the-treatment-of-small-cell-lung-cancer-48260https://curecurrent.com/trials/an-open-label-multicenter-clinical-trial-with-nivolumab-bms-936558-monotherapy-in-subjects-with-advanced-or-metastatic-s-48261https://curecurrent.com/trials/study-to-assess-the-effect-of-osimertinib-tagrisso-on-blood-levels-of-fexofenadine-in-patients-with-egfrm-nsclc-48262https://curecurrent.com/trials/predictive-assay-for-decision-making-in-adjuvant-therapy-48263https://curecurrent.com/trials/a-combination-therapy-including-anti-pd-1-immunotherapy-in-mss-rectal-cancer-with-resectable-distal-metastasis-48264https://curecurrent.com/trials/t-dm1-and-osimertinib-combination-treatment-to-target-her2-bypass-track-resistance-in-egfr-mutation-positive-nsclc-48265https://curecurrent.com/trials/mobile-health-application-of-disease-self-management-in-non-small-cell-lung-cancer-patients-during-targeted-therapy-48266https://curecurrent.com/trials/novel-lung-functional-imaging-for-personalized-radiotherapy-48267https://curecurrent.com/trials/perioperative-outcomes-of-anatomic-lung-resections-in-patients-who-recovered-from-coronavirus-disease-2019-48268https://curecurrent.com/trials/pd-1-antibody-in-addition-to-bace-in-patients-with-nsclc-a-randomised-controlled-trial-48269https://curecurrent.com/trials/rogaratinib-in-patients-with-advanced-pretreated-squamous-cell-non-small-cell-lung-cancer-sqclc-48270https://curecurrent.com/trials/tepotinib-with-gefitinib-in-participants-with-locally-advanced-or-metastatic-nsclc-insight-48271https://curecurrent.com/trials/safety-study-of-amg-228-to-treat-solid-tumors-48272https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-in-combination-with-chemotherapy-or-immunotherapy-in-participants-with-non-small-cell-l-48273https://curecurrent.com/trials/impact-of-ctdna-in-cancer-early-detection-and-stas-evaluation-in-patients-with-ggos-48274https://curecurrent.com/trials/immune-checkpoints-in-copd-48275https://curecurrent.com/trials/phase-ii-safety-single-arm-study-of-cdk4-6-inhibition-with-palbociclib-in-hospitalized-moderate-covid-19-cases-to-preven-48276https://curecurrent.com/trials/pleurectomy-decortication-p-d-preceded-or-followed-by-chemotherapy-in-patients-with-early-stage-mpm-48277https://curecurrent.com/trials/rhenium-re-188-p2045-in-patients-with-lung-cancer-who-have-received-or-refused-to-receive-prior-chemotherapy-48278https://curecurrent.com/trials/a-study-of-regn2810-and-ipilimumab-in-patients-with-lung-cancer-48279https://curecurrent.com/trials/testing-radon-com-methods-clinical-trial-smartphone-app-vs-print-brochures-48280https://curecurrent.com/trials/yorkshire-kidney-screening-trial-48281https://curecurrent.com/trials/cryotherapy-in-treating-patients-with-primary-stage-i-non-small-cell-lung-cancer-or-lung-metastasis-48282https://curecurrent.com/trials/feasibility-and-acceptability-of-an-web-based-physical-activity-program-for-those-diagnosed-with-lung-cancer-48283https://curecurrent.com/trials/measurement-of-diaphragmatic-dysfunction-after-thoracic-surgery-48284https://curecurrent.com/trials/dasatinib-in-resectable-malignant-pleural-mesothelioma-48285https://curecurrent.com/trials/electrocautery-ablation-for-the-prevention-of-lung-cancer-48286https://curecurrent.com/trials/a-study-of-t3011-administered-via-intravenously-in-patients-with-advanced-solid-tumors-48287https://curecurrent.com/trials/nivolumab-ipilimumab-and-chemotherapy-combination-in-advanced-nsclc-patients-with-hiv-hbv-hcv-and-long-covid-syndrome-48288https://curecurrent.com/trials/a-safety-trial-of-nivolumab-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-who-have-progressed-durin-48289https://curecurrent.com/trials/hypofractionated-radiotherapy-followed-by-hypo-boost-for-local-advanced-nsclc-48290https://curecurrent.com/trials/vagus-nerve-preservation-and-chronic-cough-in-non-small-cell-lung-cancer-surgery-48291https://curecurrent.com/trials/study-of-the-safety-tolerability-pharmacokinetics-and-efficacy-of-pembrolizumab-mk-3475-in-chinese-participants-with-non-48292https://curecurrent.com/trials/study-of-adi-peg-20-in-patients-with-relapsed-sensitive-or-refractory-small-cell-lung-cancer-48293https://curecurrent.com/trials/brigatinib-before-brain-irradiation-trial-b3i-trial-48294https://curecurrent.com/trials/acute-and-chronic-pain-after-video-assisted-thoracoscopic-surgery-for-lung-cancer-48295https://curecurrent.com/trials/a-real-world-study-efficacy-and-safety-of-anlotinib-for-advanced-non-small-cell-lung-cancer-nsclc-48296https://curecurrent.com/trials/blood-transfusion-in-patients-with-lung-cancer-48297https://curecurrent.com/trials/percutaneous-lung-biopsy-using-cone-beam-ct-with-virtual-guidance-a-randomized-control-trial-48298https://curecurrent.com/trials/dose-escalation-by-hypofractionated-stereotactic-radiotherapy-for-brain-metastases-in-non-small-cell-lung-cancer-48299https://curecurrent.com/trials/expanded-access-to-ensartinib-for-participants-with-alk-nsclc-48300https://curecurrent.com/trials/early-detection-and-staging-of-endobronchial-lung-and-pleural-cancer-airway-injury-and-prostate-cancer-48301https://curecurrent.com/trials/analysis-of-factors-and-treatment-related-to-chronic-cough-after-pulmonary-resection-48302https://curecurrent.com/trials/18f-fspg-pet-ct-in-imaging-patients-with-newly-diagnosed-lung-cancer-or-indeterminate-pulmonary-nodules-48303https://curecurrent.com/trials/ruxolitinib-for-newly-diagnosed-bronchiolitis-obliterans-syndrome-48304https://curecurrent.com/trials/comparision-of-various-biomarkers-between-peripheral-and-pulmonary-blood-48305https://curecurrent.com/trials/covid-19-epidemic-and-patients-with-myeloproliferative-neoplasias-48306https://curecurrent.com/trials/home-telemonitoring-for-patients-with-lung-cancer-48307https://curecurrent.com/trials/same-day-discharge-for-video-assisted-thoracoscopic-surgery-vats-lung-surgery-48308https://curecurrent.com/trials/brigatinib-and-binimetinib-in-treating-patients-with-stage-iiib-iv-alk-or-ros1-rearranged-non-small-cell-lung-cancer-48309https://curecurrent.com/trials/dynamic-monitoring-circulating-tumor-dna-in-surgical-patients-with-lung-cancer-48310https://curecurrent.com/trials/sbrt-combined-with-osimertinib-compared-with-osimertinib-for-stage-iv-nsclc-48311https://curecurrent.com/trials/phase-1-study-of-oral-rh324-in-advanced-non-small-cell-lung-cancer-48312https://curecurrent.com/trials/mk-3475-as-maintenance-therapy-in-extensive-stage-sclc-48313https://curecurrent.com/trials/lung-cancer-stars-trial-stars-revised-clinical-trial-protocol-stereotactic-ablative-radiotherapy-sabr-in-stage-i-non-sma-48314https://curecurrent.com/trials/sbrt-versus-conventional-fractionated-radiotherapy-for-vertebral-metastases-48315https://curecurrent.com/trials/pembrolizumab-as-first-line-treatment-for-advanced-nsclc-complicated-with-copd-48316https://curecurrent.com/trials/first-line-treatment-of-advanced-non-small-cell-lung-cancer-with-negative-driver-gene-a-multicenter-single-arm-trial-48317https://curecurrent.com/trials/pattern-of-isolated-fungi-from-bronchoalveolar-lavage-among-patients-with-lung-cancer-48318https://curecurrent.com/trials/a-study-of-alrn-6924-for-the-prevention-of-chemotherapy-induced-side-effects-chemoprotection-48319https://curecurrent.com/trials/phase-1-2-study-of-ensartinib-and-durvalumab-in-alk-rearranged-non-small-cell-lung-cancer-48320https://curecurrent.com/trials/phase-1-2-study-of-combination-immunotherapy-and-messenger-ribonucleic-acid-mrna-vaccine-in-subjects-with-nsclc-48321https://curecurrent.com/trials/ny-eso-1-plasmid-dna-ppjv7611-cancer-vaccine-48322https://curecurrent.com/trials/study-on-the-biological-prediction-models-of-radiation-pneumonitis-48323https://curecurrent.com/trials/study-of-hypofractionated-radiotherapy-alone-in-locally-advanced-nonsmall-cell-lung-cancer-patients-48324https://curecurrent.com/trials/acceptance-and-commitment-therapy-in-patients-with-advanced-lung-cancer-48325https://curecurrent.com/trials/heal-me-personalized-online-nutrition-and-exercise-routines-48326https://curecurrent.com/trials/ibi188-combination-therapy-in-solid-tumors-48327https://curecurrent.com/trials/prognostic-value-of-lung-cancer-microanatomy-in-3d-48328https://curecurrent.com/trials/phase-ii-trial-of-alisertib-mln8237-in-salvage-malignant-mesothelioma-48329https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-in-combination-with-etoposide-platinum-cisplatin-or-carboplatin-for-participants-with-e-48330https://curecurrent.com/trials/early-switch-maintenance-vs-delayed-second-line-nivolumab-in-advanced-stage-squamous-non-small-cell-lung-cancer-nsclc-pa-48331https://curecurrent.com/trials/radiation-therapy-and-ammonium-tetrathiomolybdate-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-48332https://curecurrent.com/trials/an-expanded-access-protocol-for-mobocertinib-in-refractory-non-small-cell-lung-cancer-nsclc-participants-with-epidermal-48333https://curecurrent.com/trials/prospective-study-in-patients-with-advanced-or-metastatic-cancer-and-sars-cov-2-infection-48334https://curecurrent.com/trials/awareness-information-and-resources-for-lung-cancer-screening-program-for-community-partnered-lung-cancer-screening-48335https://curecurrent.com/trials/a-phase-i-study-of-ips-cell-generation-from-patients-with-copd-48336https://curecurrent.com/trials/oxidoreductive-balance-and-lysosomal-activity-in-cancer-patients-48337https://curecurrent.com/trials/randomized-phase-ii-open-label-efficacy-and-safety-study-of-second-line-durvalumab-plus-tremelimumab-versus-platinum-bas-48338https://curecurrent.com/trials/bay-59-8862-in-treating-patients-with-non-small-cell-lung-cancer-48339https://curecurrent.com/trials/pharmacokinetic-boosting-of-osimertinib-48340https://curecurrent.com/trials/covid19-hematological-malignancies-the-italian-hematology-alliance-48341https://curecurrent.com/trials/a-study-of-epacadostat-in-combination-with-pembrolizumab-and-chemotherapy-in-participants-with-advanced-or-metastatic-so-48342https://curecurrent.com/trials/pilot-study-of-a-novel-type-of-ct-scan-to-assess-treatment-response-during-chemoradiotherapy-for-stage-iii-non-small-cel-48343https://curecurrent.com/trials/an-efficacy-study-of-morab-009-amatuximab-in-subjects-with-pleural-mesothelioma-48344https://curecurrent.com/trials/detection-of-resistance-mechanisms-in-cerebrospinal-fluid-for-egfr-mutant-alk-and-ros1-rearranged-48345https://curecurrent.com/trials/first-line-furmonertinib-in-advanced-nsclc-patients-with-egfr-uncommon-mutation-48346https://curecurrent.com/trials/heterogeneously-hypofractionated-radiotherapy-for-locally-advanced-nsclc-48347https://curecurrent.com/trials/virtual-management-of-lung-nodules-48348https://curecurrent.com/trials/stereotactic-body-radiotherapy-versus-conventional-radiotherapy-in-medically-inoperable-non-small-lung-cancer-patients-48349https://curecurrent.com/trials/keapsake-a-study-of-telaglenastat-cb-839-with-standard-of-care-chemoimmunotherapy-in-1l-keap1-nrf2-mutated-nonsquamous-n-48350https://curecurrent.com/trials/multicenter-prospective-real-world-study-of-camrelizumab-in-cross-line-treatment-of-non-small-cell-lung-cancer-48351https://curecurrent.com/trials/lung-perfusion-pet-ct-using-ga68-maa-for-preservation-of-lung-function-during-stereotactic-pulmonary-radiation-therapy-48352https://curecurrent.com/trials/postoperative-anesthesia-care-facial-mask-vs-hfnc-and-thoracic-ultrasound-for-reduction-of-atelectasis-incidence-48353https://curecurrent.com/trials/cardio-pulmonary-and-analgesic-effects-of-pre-peritoneal-vs-epidural-infusion-of-l-bupivacaine-on-abd-cancer-patients-48354https://curecurrent.com/trials/a-phase-i-study-of-wm-s1-030-in-patients-with-advanced-solid-tumors-48355https://curecurrent.com/trials/deep-learning-model-for-pure-solid-nodules-classification-48356https://curecurrent.com/trials/it-is-possible-to-maintain-the-performance-of-screening-colonoscopies-under-meopa-during-the-covid-19-epidemic-period-wh-48357https://curecurrent.com/trials/sbrt-dose-escalation-for-reirradiation-of-inoperable-lung-lesions-48358https://curecurrent.com/trials/adjuvant-treatment-based-on-mrd-for-egfr-mutant-nsclc-48359https://curecurrent.com/trials/envafolimab-immunotherapy-after-ctdna-egfr-clearance-by-treatment-with-almonertinib-in-egfr-mutant-pd-li-positive-nsclc-48360https://curecurrent.com/trials/clinical-trial-of-sbrt-and-systemic-pembrolizumab-with-or-without-avelumab-ipilimumab-dendritic-cells-in-solid-tumors-48361https://curecurrent.com/trials/pemetrexed-in-advanced-non-small-cell-lung-cancer-48362https://curecurrent.com/trials/retrospective-study-evaluating-igf1r-and-p95her2-as-prognostic-factors-in-non-small-cell-lung-cancer-nsclc-48363https://curecurrent.com/trials/vopratelimab-and-a-ctla-4-inhibitor-in-pd-1-pd-l1-inhibitor-experienced-subjects-with-nsclc-or-urothelial-cancer-48364https://curecurrent.com/trials/mono-versus-polichemotherapy-in-non-small-cell-lung-cancer-nsclc-elderly-patients-48365https://curecurrent.com/trials/pharmacogenetics-of-vinorelbine-in-malignant-pleural-mesothelioma-patients-48366https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-efficacy-of-atezolizumab-in-previously-treated-patients-with-locally-advanced-or-m-48367https://curecurrent.com/trials/observational-prospective-analysis-of-biological-characteristics-of-mesothelioma-patients-48368https://curecurrent.com/trials/a-study-to-determine-safety-tolerability-pharmacokinetics-and-recommended-phase-2-dose-rp2d-of-intravenous-abbv-184-in-a-48369https://curecurrent.com/trials/efficacy-and-safety-of-microwave-ablation-combined-with-camrelizumab-and-chemotherapy-in-patients-with-advanced-non-smal-48370https://curecurrent.com/trials/patient-s-whole-process-follow-up-management-hope-1-48371https://curecurrent.com/trials/a-study-of-nivolumab-nab-paclitaxel-in-non-small-cell-lung-cancer-48372https://curecurrent.com/trials/concurrent-once-daily-versus-twice-daily-radiotherapy-for-limited-stage-small-cell-lung-cancer-48373https://curecurrent.com/trials/effect-and-safety-of-envafolimab-combined-with-endostar-s-1-in-second-line-of-advanced-non-small-cell-lung-cancer-48374https://curecurrent.com/trials/study-of-surufatinib-combined-with-sintilimab-and-scrt-in-advanced-solid-tumors-48375https://curecurrent.com/trials/preoperative-treatment-of-respiratory-physiotherapy-in-lung-cancer-48376https://curecurrent.com/trials/tunneled-pleural-catheter-in-partially-entrapped-lung-48377https://curecurrent.com/trials/dose-escalation-of-rmc-4630-monotherapy-in-relapsed-refractory-solid-tumors-48378https://curecurrent.com/trials/furmonertinib-monotherapy-and-combination-therapy-in-advanced-egfr-mutant-nsclc-with-uncleared-ctdna-48379https://curecurrent.com/trials/pneumococcal-vaccination-of-multiple-myeloma-patients-on-novel-agents-48380https://curecurrent.com/trials/covid-ehr-cohort-at-the-university-of-wisconsin-48381https://curecurrent.com/trials/omitting-clinical-target-volume-of-unresectable-stage-iii-non-small-cell-lung-cancer-48382https://curecurrent.com/trials/sbrt-combined-with-pd-1-inhibitor-and-thoracic-hyperthermia-for-advanced-nsclc-48383https://curecurrent.com/trials/a-study-of-xzp-5955-tablets-in-patients-with-ntrk-or-ros1-fusion-positive-locally-advanced-or-metastatic-solid-tumors-48384https://curecurrent.com/trials/sunitinib-malate-and-combination-chemotherapy-as-front-line-therapy-in-treating-patients-with-metastatic-rectal-cancer-t-48385https://curecurrent.com/trials/phase-1b-2-study-of-liposomal-annamycin-l-annamycin-in-subjects-with-previously-treated-soft-tissue-sarcomas-sts-with-pu-48386https://curecurrent.com/trials/n-acetylcysteine-vs-placebo-to-prevent-neurotoxicity-induced-by-platinum-containing-chemotherapy-48387https://curecurrent.com/trials/immune-checkpoint-inhibitors-and-atherosclerotic-plaque-volume-48388https://curecurrent.com/trials/a-multicenter-prospective-study-to-assess-the-effects-of-adjuvant-icotinib-in-egfrm-stage-i-nsclc-with-high-risk-of-dise-48389https://curecurrent.com/trials/biomarkers-of-early-chronic-obstructive-pulmonary-disease-copd-in-smokers-longitudinal-study-48390https://curecurrent.com/trials/trial-exploring-combined-neoadjuvant-therapy-with-pembrolizumab-lenvatinib-adjuvant-pembrolizumab-in-pat-with-nsclc-48391https://curecurrent.com/trials/breath-analysis-by-ion-mobility-spectrometry-48392https://curecurrent.com/trials/real-world-effectiveness-of-osimertinib-for-patients-with-non-small-cell-lung-cancer-48393https://curecurrent.com/trials/prognostic-value-of-body-composition-in-lung-cancer-48394https://curecurrent.com/trials/resistance-inspiratory-muscle-training-for-patients-with-thoracic-malignancies-48395https://curecurrent.com/trials/study-to-evaluate-erlotinib-with-or-without-sndx-275-entinostat-in-the-treatment-of-patients-with-advanced-nsclc-48396https://curecurrent.com/trials/effect-of-hithoc-after-pleurectomy-decortication-for-treatment-of-malignant-pleural-mesothelioma-48397https://curecurrent.com/trials/phase-ib-ii-study-of-shr-8068-injection-in-the-treatment-of-advanced-non-small-cell-lung-cancer-48398https://curecurrent.com/trials/study-of-epacadostat-incb024360-alone-and-in-combination-with-pembrolizumab-mk-3475-with-chemotherapy-and-pembrolizumab-48399https://curecurrent.com/trials/study-of-osimertinib-bevacizumab-chemotherapy-for-egfr-advanced-non-small-cell-lung-cancer-with-concurrent-mutations-48400https://curecurrent.com/trials/study-of-dll3-car-nk-cells-in-the-treatment-of-extensive-stage-small-cell-lung-cancer-48401https://curecurrent.com/trials/impact-of-concomitant-genetic-alterations-in-egfr-mutated-adenocarcinoma-by-ngs-analysis-a-multicenter-study-48402https://curecurrent.com/trials/tc99m-macroaggregated-albumin-bronchial-artery-study-48403https://curecurrent.com/trials/phase-i-iia-study-of-br790-in-combination-with-tislelizumab-in-adult-subjects-with-advanced-solid-tumors-48404https://curecurrent.com/trials/a-study-of-ensartinib-as-neoadjuvant-therapy-for-patients-with-alk-positive-resectable-non-small-cell-lung-cancer-48405https://curecurrent.com/trials/the-leukemia-and-lymphoma-society-lls-t-cells-in-blood-cancer-and-covid-19-48406https://curecurrent.com/trials/optimal-egfr-tkis-treatment-strategies-for-lung-adenocarcinoma-harboring-egfr-exon-19-deletion-variants-48407https://curecurrent.com/trials/phase-ib-ii-study-of-almonertinib-combined-with-shr-1701-in-the-treatment-of-relapsed-or-advanced-non-small-cell-lung-ca-48408https://curecurrent.com/trials/neoadjuvant-furmonertinib-plus-bevacizumab-or-furmonertinib-monotherapy-for-resectable-and-potentially-resectable-stage-48409https://curecurrent.com/trials/interest-of-cpet-to-predict-mortality-and-complications-of-lung-resection-candidates-48410https://curecurrent.com/trials/a-study-of-camrelizumab-plus-apatinib-as-consolidation-therapy-in-non-small-cell-lung-cancer-patients-treated-with-chemo-48411https://curecurrent.com/trials/comparison-of-inflammatory-cytokine-levels-between-single-port-and-three-port-thoracoscopic-lobectomy-in-the-treatment-o-48412https://curecurrent.com/trials/bevacizumab-docetaxel-and-gemcitabine-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-48413https://curecurrent.com/trials/prospective-trial-of-induction-immunotherapy-in-locally-advanced-or-oligometastatic-nsclc-without-a-primary-curative-opt-48414https://curecurrent.com/trials/exercise-capacity-pulmonary-function-and-physical-activity-level-in-patients-lung-cancer-undergoing-pneumonectomy-48415https://curecurrent.com/trials/pdr001-in-combination-with-platinum-doublet-chemotherapy-and-other-immunology-agents-in-pd-l1-unselected-metastatic-nscl-48416https://curecurrent.com/trials/validation-of-low-dose-ct-for-diagnosis-of-lung-nodules-48417https://curecurrent.com/trials/premo-study-to-investigate-port-removal-outcomes-48418https://curecurrent.com/trials/a-study-of-l-dos47-in-combination-with-vinorelbine-cisplatin-in-lung-adenocarcinoma-48419https://curecurrent.com/trials/the-efficacy-and-safety-of-dalpiciclib-combined-with-third-generation-egfr-tki-in-patients-with-egfr-mutation-and-mening-48420https://curecurrent.com/trials/combination-of-cetuximab-with-afatinib-for-patient-with-egfr-mutated-lung-cancer-48421https://curecurrent.com/trials/comparative-study-on-the-efficacy-and-safety-of-microwave-ablation-and-lobectomy-in-the-treatment-of-ground-glass-nodule-48422https://curecurrent.com/trials/ore-30-seconds-oncologists-recommend-exercise-in-30-secs-48423https://curecurrent.com/trials/a-real-world-study-of-ensartinib-in-advanced-alk-positive-nsclc-48424https://curecurrent.com/trials/safety-and-immune-response-of-covid-19-vaccination-in-patients-with-basic-disease-48425https://curecurrent.com/trials/pembrolizumab-and-magnetic-resonance-imaging-with-ferumoxytol-in-treating-patients-with-non-small-cell-lung-cancer-and-b-48426https://curecurrent.com/trials/post-surgical-non-small-cell-lung-cancer-nsclc-follow-up-48427https://curecurrent.com/trials/circulating-tumor-dna-guided-therapeutic-strategies-for-crc-patients-with-small-pulmonary-nodules-48428https://curecurrent.com/trials/lci-lun-abr-001-carbo-with-nab-paclitaxel-in-patients-with-advanced-nscl-cancer-48429https://curecurrent.com/trials/covid19-foie-national-observatory-48430https://curecurrent.com/trials/early-treatment-with-ivermectin-and-losartan-for-cancer-patients-with-covid-19-infection-48431https://curecurrent.com/trials/china-lung-cancer-screening-clus-study-version-3-0-48432https://curecurrent.com/trials/prospective-post-market-data-collection-for-ion-endoluminal-system-to-understand-ct-to-body-divergence-48433https://curecurrent.com/trials/clinical-evaluation-of-primary-sampling-scatter-correction-for-chest-tomosynthesis-48434https://curecurrent.com/trials/educating-providers-about-lung-screening-48435https://curecurrent.com/trials/a-safety-tolerability-pk-and-preliminary-activity-study-of-gb263t-in-advanced-nsclc-and-other-solid-tumor-48436https://curecurrent.com/trials/effect-of-low-tidal-ventilation-on-intraoperative-bleeding-in-laparoscopic-major-hepatectomy-48437https://curecurrent.com/trials/durvalumab-combined-with-consolidation-radiotherapy-after-first-line-treatment-in-extensive-stage-small-cell-lung-cancer-48438https://curecurrent.com/trials/a-study-of-oncolytic-virus-injection-rt-01-in-patients-with-extensive-stage-small-cell-lung-cancer-48439https://curecurrent.com/trials/ctdna-as-a-biomarker-for-treatment-in-advanced-nsclc-48440https://curecurrent.com/trials/studies-examining-the-importance-of-smoking-after-being-diagnosed-with-lung-cancer-48441https://curecurrent.com/trials/mpdl3280a-and-stereotactic-ablative-radiotherapy-in-patients-with-non-small-cell-lung-cancer-48442https://curecurrent.com/trials/efficacy-and-safety-of-furmonertinib-in-egfr-mutant-pd-l1-patients-with-locally-advanced-or-metastatic-nsclc-future-48443https://curecurrent.com/trials/establishment-of-the-human-intestinal-and-salivary-microbiota-biobank-oncologic-diseases-48444https://curecurrent.com/trials/study-of-ha121-28-in-patients-with-non-small-cell-lung-cancer-48445https://curecurrent.com/trials/anlotinib-penpulimab-combined-with-sbrt-for-metastatic-non-small-cell-lung-cancer-nsclc-48446https://curecurrent.com/trials/self-system-therapy-for-older-adults-with-lung-cancer-48447https://curecurrent.com/trials/collection-and-storage-of-blood-and-tissue-samples-from-patients-who-are-undergoing-surgery-for-lung-cancer-48448https://curecurrent.com/trials/pulmonary-rehabilitation-after-minimal-invasive-surgery-in-lung-cancer-48449https://curecurrent.com/trials/study-evaluating-cmp-001-in-combination-with-atezolizumab-in-participants-with-non-small-cell-lung-cancer-48450https://curecurrent.com/trials/ex-vivo-delivery-of-rituximab-to-prevent-ptld-in-ebv-mismatch-lung-transplant-recipients-a-pilot-trial-48451https://curecurrent.com/trials/pamiparib-for-consolidation-treatment-of-unprogressed-ls-sclc-after-concurrent-chemoradiotherapy-48452https://curecurrent.com/trials/a-clinical-study-of-lm103-injection-in-the-treatment-of-advanced-solid-tumors-48453https://curecurrent.com/trials/the-association-of-microbiota-composition-with-cgvhd-after-allo-hsct-48454https://curecurrent.com/trials/marrow-infiltrating-lymphocytes-non-small-cell-lung-cancer-mils-nsclc-alone-or-in-combination-with-nivolumab-with-or-wit-48455https://curecurrent.com/trials/assessment-of-anti-tumor-and-safety-in-glumetinib-in-patients-with-c-met-positive-non-small-cell-lung-cancer-48456https://curecurrent.com/trials/a-study-of-xzp-3621-in-chinese-patients-with-alk-positive-nsclc-48457https://curecurrent.com/trials/liver-sbrt-in-combination-with-immune-checkpoint-inhibition-in-patients-with-metastatic-non-small-cell-lung-cancer-48458https://curecurrent.com/trials/spleen-radiotherapy-decreases-severe-cit-in-advanced-nsclc-spleenir-48459https://curecurrent.com/trials/anti-sars-cov2-vaccination-study-in-lung-cancer-patients-48460https://curecurrent.com/trials/neoadjuvant-therapy-in-resectable-non-small-cell-lung-cancer-stages-iib-iiib-48461https://curecurrent.com/trials/ideal-artificial-intelligence-and-big-data-for-early-lung-cancer-diagnosis-study-48462https://curecurrent.com/trials/impact-of-confinement-and-preventive-measures-in-period-of-sars-cov2-infection-on-clinical-features-diagnostic-and-thera-48463https://curecurrent.com/trials/lazertinib-pemetrexed-carboplatin-after-osimertinib-failure-in-nsclc-with-brain-metastases-48464https://curecurrent.com/trials/bintrafusp-alfa-before-surgery-for-the-treatment-of-untreated-resectable-non-small-cell-lung-cancer-48465https://curecurrent.com/trials/innovative-approach-to-reduce-lung-cancer-stigma-48466https://curecurrent.com/trials/added-value-of-cone-beam-ct-guidance-to-electromagnetic-navigation-bronchoscopy-for-the-diagnosis-of-pulmonary-nodule-48467https://curecurrent.com/trials/meaning-of-recovery-after-lung-cancer-surgery-48468https://curecurrent.com/trials/us-nab-with-rose-versus-us-fnab-with-no-rose-48469https://curecurrent.com/trials/management-of-tobacco-treatment-intervention-in-reducing-surgical-complications-in-patients-with-newly-diagnosed-lung-ca-48470https://curecurrent.com/trials/the-canada-lymph-node-score-project-a-crossover-trial-48471https://curecurrent.com/trials/a-phase-i-clinical-trial-of-bevacizumab-injection-48472https://curecurrent.com/trials/correlation-between-efficacy-of-osimertinib-and-egfr-t790m-status-and-ratio-via-ddpcr-in-nsclc-48473https://curecurrent.com/trials/phase-i-ii-study-of-ck-101-in-nsclc-patients-and-other-advanced-solid-tumors-48474https://curecurrent.com/trials/a-study-of-fwd1509-in-adults-with-non-small-cell-lung-cancer-48475https://curecurrent.com/trials/influence-of-biopsy-technique-on-moleculargenetic-tumor-characterisation-in-nsclc-48476https://curecurrent.com/trials/five-fraction-sabr-dose-escalation-for-early-stage-squamous-cell-carcinoma-of-the-lung-48477https://curecurrent.com/trials/camrelizumab-combination-with-sbrt-and-concurrent-chemotherapy-treated-stage-iv-oligometastatic-non-small-cell-lung-canc-48478https://curecurrent.com/trials/tr-freeze-spray-cryotherapy-patient-registry-48479https://curecurrent.com/trials/a-study-of-plx2853-in-advanced-malignancies-48480https://curecurrent.com/trials/home-based-exercise-training-for-lung-cancer-patients-awaiting-surgery-48481https://curecurrent.com/trials/study-of-nov-002-in-combination-with-chemotherapy-to-treat-lung-cancer-48482https://curecurrent.com/trials/cisplatin-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-or-lung-metastasis-48483https://curecurrent.com/trials/efficacy-and-safety-of-perioperative-use-of-breztri-aerosphere-to-relieve-cough-after-lobectomy-48484https://curecurrent.com/trials/implementation-of-smoking-cessation-within-nci-community-oncology-research-program-ncorp-sites-48485https://curecurrent.com/trials/photodynamic-therapy-during-surgery-in-treating-patients-with-non-small-cell-lung-cancer-that-can-be-removed-by-surgery-48486https://curecurrent.com/trials/a-volume-motion-and-anatomically-adaptive-approach-to-photon-and-proton-beam-radiotherapy-48487https://curecurrent.com/trials/a-study-of-atezolizumab-in-patients-with-unresectable-locally-advanced-or-metastatic-nsclc-j-tail-48488https://curecurrent.com/trials/stereotactic-body-radiation-therapy-after-surgery-in-treating-patients-with-stage-iii-iv-non-small-cell-lung-cancer-48489https://curecurrent.com/trials/neoadjuvant-lazertinib-therapy-in-egfr-mutation-positive-lung-adenocarcinoma-detected-by-balf-liquid-biopsy-48490https://curecurrent.com/trials/f16il2-in-combination-with-nivolumab-in-patients-with-non-small-cell-lung-cancer-48491https://curecurrent.com/trials/educational-intervention-for-the-promotion-of-knowledge-and-preventive-health-behaviors-related-to-personal-air-pollutio-48492https://curecurrent.com/trials/frequency-of-sars-covid-19-infection-among-malignant-patients-at-south-egypt-cancer-institute-48493https://curecurrent.com/trials/anlotinib-plus-penpulimab-in-advanced-non-small-cell-lung-cancer-previously-treated-with-pd-1-pd-l1-inhibitors-48494https://curecurrent.com/trials/immunological-profile-changes-in-patients-with-advanced-non-small-cell-lung-cancer-48495https://curecurrent.com/trials/pet-ct-imaging-of-angiogenesis-in-lung-or-head-and-neck-cancers-prior-or-during-chemotherapy-with-antiangiogenic-agents-48496https://curecurrent.com/trials/study-of-bo-112-with-radiotherapy-and-nivolumab-for-metastatic-refractory-nsclc-48497https://curecurrent.com/trials/apatinib-for-extensive-stage-small-cell-lung-cancer-after-second-third-line-chemotherapy-48498https://curecurrent.com/trials/postoperative-analgesia-with-a-catheter-under-the-erector-spinae-muscle-for-videothoracoscopic-lung-surgery-48499https://curecurrent.com/trials/lung-health-check-biomarker-study-48500https://curecurrent.com/trials/titan-1-safety-proliferation-and-persistence-of-gen-011-autologous-cell-therapy-48501https://curecurrent.com/trials/sintilimab-combined-with-anlotinib-for-perioperative-non-small-cell-lung-cancer-based-on-mrd-evaluation-48502https://curecurrent.com/trials/study-of-chemotherapy-and-pd-1-inhibitor-combination-with-anti-angiogenesis-to-treat-elderly-lung-cancer-48503https://curecurrent.com/trials/phase-3-study-of-tavocept-versus-placebo-in-patients-with-newly-diagnosed-or-relapsed-advanced-primary-adenocarcinoma-of-48504https://curecurrent.com/trials/study-of-bevacizumab-and-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-48505https://curecurrent.com/trials/neoadjuvant-of-sintilimab-combined-with-chemotherapy-for-resectable-nsclc-neoscore-48506https://curecurrent.com/trials/a-study-of-apg-1252-in-patients-with-sclc-or-other-solid-tumors-48507https://curecurrent.com/trials/study-of-apg-1252-plus-paclitaxel-in-patients-with-relapsed-refractory-small-cell-lung-cancer-48508https://curecurrent.com/trials/single-agent-chemotherapy-nivolumab-in-patients-with-advanced-squamous-or-non-squamous-nsclc-with-primary-resistance-to-48509https://curecurrent.com/trials/an-open-label-phase-2trial-of-sotorasib-in-kras-g12c-mutant-non-small-cell-lung-cancer-nsclc-patients-and-a-translationa-48510https://curecurrent.com/trials/recombinant-human-angioendostatin-pd-1-mab-combined-with-first-line-chemotherapy-in-the-treatment-of-driver-gene-negativ-48511https://curecurrent.com/trials/a-study-of-famitinib-in-combination-with-hs-10296-in-patients-with-egfr-mutant-nsclc-48512https://curecurrent.com/trials/efficacy-and-safety-of-lanreotide-autogel-depot-120-mg-vs-placebo-in-subjects-with-lung-neuroendocrine-tumours-48513https://curecurrent.com/trials/testing-the-feasibility-of-a-simplified-workflow-for-lung-cancer-48514https://curecurrent.com/trials/a-safety-and-efficacy-of-pomalyst-capsules-under-the-actual-use-in-all-patients-who-are-treated-with-pomalyst-at-a-dose-48515https://curecurrent.com/trials/tislelizumab-combined-with-anlotinib-and-2-cycles-irinotecan-as-second-line-treatment-of-sclc-48516https://curecurrent.com/trials/e-gfr-tki-and-egf-p-ti-c-ombination-in-egfr-muta-nt-nscl-c-48517https://curecurrent.com/trials/classification-of-benign-and-malignant-lung-nodules-based-on-ct-raw-data-48518https://curecurrent.com/trials/methoxyamine-hydrochloride-pemetrexed-disodium-cisplatin-and-radiation-therapy-in-treating-patients-with-stage-iiia-iv-n-48519https://curecurrent.com/trials/prospective-cohort-study-to-describe-the-clinical-characteristics-of-covid-19-the-acquired-immune-response-and-the-biolo-48520https://curecurrent.com/trials/radiomics-combined-with-frozen-section-prediction-model-for-spread-through-air-space-in-lung-adenocarcinoma-48521https://curecurrent.com/trials/optimising-cancer-therapy-and-identifying-causes-of-pneumonitis-using-artificial-intelligence-covid-19-48522https://curecurrent.com/trials/application-of-ultrasound-guided-thoracic-paravertebral-block-in-pulmonary-ablation-surgery-48523https://curecurrent.com/trials/study-of-nivolumab-bms-936558-in-patients-with-advanced-or-metastatic-squamous-cell-nonsmall-cell-lung-cancer-who-have-r-48524https://curecurrent.com/trials/phase-1-2-study-of-hs-10376-in-patients-with-non-small-cell-lung-cancer-48525https://curecurrent.com/trials/intraoperative-imaging-of-pulmonary-nodules-by-otl38-48526https://curecurrent.com/trials/nivolumab-combined-with-anlotinib-as-re-challenge-treatment-in-advanced-nsclc-48527https://curecurrent.com/trials/lung-and-melanoma-cancer-patients-covid19-disease-gravid-48528https://curecurrent.com/trials/trial-of-pi-88-with-docetaxel-in-advanced-non-small-cell-lung-cancer-nsclc-48529https://curecurrent.com/trials/docetaxel-with-or-without-pi-88-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-48530https://curecurrent.com/trials/a-phase-iia-study-to-evaluate-the-efficacy-and-safety-of-6mw3211-in-patients-with-advanced-lung-cancer-48531https://curecurrent.com/trials/tas-102-in-previously-treated-unresectable-or-metastatic-squamous-cell-lung-carcinoma-uf-sto-lung-003-48532https://curecurrent.com/trials/cerebral-prophylactic-irradiation-with-saving-hippocampus-and-amygdala-48533https://curecurrent.com/trials/minimizing-pathologic-aspiration-in-patients-undergoing-esophageal-and-lung-resections-for-cancer-48534https://curecurrent.com/trials/sym015-anti-met-in-patients-with-advanced-solid-tumor-malignancies-48535https://curecurrent.com/trials/exploratory-interventional-study-of-prognostic-serum-biomarkers-of-cancer-progression-48536https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-using-a-22-vs-25-gauge-needle-48537https://curecurrent.com/trials/tab008-compared-to-avastin-in-patients-with-egfr-wild-type-non-squamous-non-small-cell-lung-cancer-48538https://curecurrent.com/trials/image-guided-hypofractionated-radiation-therapy-nelfinavir-mesylate-pembrolizumab-nivolumab-and-atezolizumab-in-treating-48539https://curecurrent.com/trials/bi-2536-second-line-monotherapy-in-sclc-48540https://curecurrent.com/trials/use-of-nmoabs-for-the-treatment-of-covid-19-in-patients-with-hm-48541https://curecurrent.com/trials/identification-of-circulating-tumor-cells-in-the-peripheral-blood-of-lung-cancer-patients-48542https://curecurrent.com/trials/high-dose-or-standard-dose-radiation-therapy-and-chemotherapy-with-or-without-cetuximab-in-treating-patients-with-newly-48543https://curecurrent.com/trials/efficacy-and-safety-of-bi-2536-in-advanced-or-metastatic-non-small-cell-lung-cancer-48544https://curecurrent.com/trials/clinical-characteristics-of-lung-cancer-in-china-48545https://curecurrent.com/trials/artificial-intelligence-system-for-assessment-of-tumor-risk-and-diagnosis-and-treatment-48546https://curecurrent.com/trials/a-study-of-shr-1316-and-fluzoparib-shr-3162-in-small-cell-lung-cancer-patients-48547https://curecurrent.com/trials/a-study-of-gdc-0853-in-patients-with-resistant-b-cell-lymphoma-or-chronic-lymphocytic-leukemia-48548https://curecurrent.com/trials/phase-1-study-of-bpi-442096-in-advanced-solid-tumor-patients-48549https://curecurrent.com/trials/intraoperative-imaging-of-pulmonary-nodules-by-sgm-101-48550https://curecurrent.com/trials/mtg201-plus-nivolumab-in-patients-with-relapsed-pleural-mesothelioma-48551https://curecurrent.com/trials/eucross-european-trial-on-crizotinib-in-ros1-translocated-lung-cancer-48552https://curecurrent.com/trials/a-phase-iii-study-to-assess-the-effects-of-almonertinib-following-chemoradiation-in-patients-with-stage-iii-unresectable-48553https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-with-or-without-panitumumab-in-treating-patients-with-stage-iiia-non-small-cell-lung-48554https://curecurrent.com/trials/feasibility-and-safety-study-of-nivolumab-with-irinotecan-for-small-cell-lung-cancer-48555https://curecurrent.com/trials/a-safety-and-efficacy-study-of-revlimid-5-mg-capsules-in-patients-with-relapsed-or-refractory-multiple-myeloma-who-have-48556https://curecurrent.com/trials/cabozantinib-with-pemetrexed-in-advanced-non-small-cell-lung-cancer-urothelial-cancer-and-malignant-mesothelioma-48557https://curecurrent.com/trials/afatinib-on-cns-metastases-and-lmd-in-egfr-mutation-positive-nsclc-48558https://curecurrent.com/trials/assessment-of-relationship-between-preoperative-nutritional-status-and-perioperative-postoperative-conditions-in-patient-48559https://curecurrent.com/trials/a-study-of-concurrent-chemoradiation-with-atezolizumab-in-participants-with-untreated-extensive-stage-es-small-cell-lung-48560https://curecurrent.com/trials/hospital-acquired-pneumonia-in-temporary-tracheostomy-48561https://curecurrent.com/trials/study-of-nivolumab-verses-nivolumab-and-ipilimumab-combination-in-egfr-mutant-non-small-cell-lung-cancer-48562https://curecurrent.com/trials/a-study-of-special-use-results-surveillance-of-revlimid-5mg-capsules-48563https://curecurrent.com/trials/bosutinib-in-combination-with-pemetrexed-in-patients-with-selected-metastatic-solid-tumors-48564https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-compared-to-platinum-based-chemotherapies-in-participants-with-metastatic-non-small-cell-48565https://curecurrent.com/trials/neoadjuvant-or-adjuvant-chemotherapy-in-patients-with-operable-non-small-cell-lung-cancer-48566https://curecurrent.com/trials/beneficial-effect-of-pulmonary-rehabilitation-in-lung-cancer-patients-receiving-radiation-therapy-48567https://curecurrent.com/trials/a-study-of-envafolimab-in-subjects-with-stage-iii-non-small-cell-lung-cancer-48568https://curecurrent.com/trials/the-ctdna-for-evaluating-whether-to-use-adjuvant-therapy-after-sbrt-in-patients-with-early-lung-cancer-48569https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-48570https://curecurrent.com/trials/a-real-world-study-of-pyrotinib-maleate-in-the-treatment-of-advanced-metastatic-non-small-cell-lung-cancer-with-rare-mut-48571https://curecurrent.com/trials/explore-the-sharing-model-intervene-to-improve-the-knowledge-attitudes-service-intentions-and-service-start-up-effects-o-48572https://curecurrent.com/trials/spanish-real-world-data-on-patients-treated-with-durvalumab-after-chemoradiotherapy-48573https://curecurrent.com/trials/study-of-avelumab-and-cetuximab-plus-gemcitabine-and-cisplatin-in-participants-with-nsclc-48574https://curecurrent.com/trials/phase-ii-trial-of-sequential-consolidation-with-pembrolizumab-followed-by-nab-paclitaxel-48575https://curecurrent.com/trials/osimertinib-in-subjects-with-advanced-non-small-cell-lung-cancer-egfr-t790m-mutation-positive-48576https://curecurrent.com/trials/outcomes-mandate-national-integration-with-cannabis-as-medicine-48577https://curecurrent.com/trials/covid-19-detection-test-in-oncology-48578https://curecurrent.com/trials/china-lung-cancer-screening-clus-study-version-2-0-48579https://curecurrent.com/trials/a-dose-finding-study-of-the-second-mitochondrial-activator-of-caspases-smac-mimetic-debio-1143-when-given-in-combination-48580https://curecurrent.com/trials/a-mobile-smart-exercise-support-program-to-improve-fatigue-in-lung-cancer-patients-a-rct-48581https://curecurrent.com/trials/a-study-of-participants-in-australia-who-have-non-small-cell-lung-cancer-being-treated-with-nivolumab-48582https://curecurrent.com/trials/tislelizumab-bevacizumab-pc-for-untreated-egfr-and-high-pd-l1-non-squamous-nsclc-48583https://curecurrent.com/trials/pdr001-plus-lag525-for-patients-with-advanced-solid-and-hematologic-malignancies-48584https://curecurrent.com/trials/study-to-assess-the-safety-of-nivolumab-in-the-treatment-of-metastatic-melanoma-lung-cancer-renal-cancer-squamous-cell-c-48585https://curecurrent.com/trials/exhaled-breath-particles-in-lung-cancer-48586https://curecurrent.com/trials/sapanisertib-and-nivolumab-for-the-treatment-of-stage-i-iv-non-small-cell-lung-cancer-in-patients-who-have-progressed-on-48587https://curecurrent.com/trials/platinum-based-chemotherapy-plus-ramucirumab-in-patients-with-advanced-nsclc-who-have-progressed-on-first-line-anti-pd-1-48588https://curecurrent.com/trials/pd1-and-parp-for-maintenance-therapy-in-nsllc-48589https://curecurrent.com/trials/endobronchial-ultrasound-needle-aspiration-with-and-without-suction-48590https://curecurrent.com/trials/conventional-vs-ultrathin-bronchoscopy-for-peripheral-pulmonary-lesions-48591https://curecurrent.com/trials/observational-study-for-lung-cancer-patients-treated-with-nivolumab-48592https://curecurrent.com/trials/penpulimab-combined-with-anlotinib-in-neoadjuvant-treatment-of-resectable-non-small-cell-lung-cancer-48593https://curecurrent.com/trials/ai-radiomics-for-stratification-of-lung-nodules-after-radically-treated-cancer-48594https://curecurrent.com/trials/sbrt-for-oligoprogressive-nsclc-after-first-line-treatment-with-immune-checkpoint-inhibitors-48595https://curecurrent.com/trials/immune-boost-in-non-small-cell-lung-cancer-48596https://curecurrent.com/trials/clinical-observation-of-ici-combined-with-recombinant-human-endostatin-on-leptomeningeal-metastasis-of-lung-cancer-48597https://curecurrent.com/trials/immune-response-to-the-covid-19-vaccine-48598https://curecurrent.com/trials/observational-study-of-the-efficacy-and-safety-of-anlotinib-combined-with-penpulimab-in-elderly-lung-cancer-patients-48599https://curecurrent.com/trials/salvage-surgery-following-downstaging-of-advanced-non-small-cell-lung-cancer-by-targeted-therapy-sdant-48600https://curecurrent.com/trials/brain-metabolic-network-of-pet-in-patients-with-advanced-non-small-cell-lung-cancer-48601https://curecurrent.com/trials/yorkshire-enhanced-stop-smoking-study-48602https://curecurrent.com/trials/the-red-blood-cells-based-blood-test-for-lung-cancer-early-detection-48603https://curecurrent.com/trials/a-phase-iib-study-of-bpi-7711-capsule-in-non-small-cell-lung-cancer-patients-with-t790m-mutation-positive-48604https://curecurrent.com/trials/high-intensity-functional-image-guided-vmat-lung-evasion-48605https://curecurrent.com/trials/lazertinib-real-world-observational-study-of-in-pre-treated-egfr-t790m-mutant-with-advanced-non-small-cell-lung-cancer-48606https://curecurrent.com/trials/impact-of-the-immune-system-on-response-to-anti-coronavirus-disease-19-covid-19-vaccine-in-allogeneic-stem-cell-recipien-48607https://curecurrent.com/trials/efficacy-and-safety-of-deb-bace-with-sequential-arotinib-and-tirelizumab-in-the-treatment-of-advanced-nsclc-48608https://curecurrent.com/trials/screening-of-alberta-asbestos-exposed-workers-for-lung-cancer-and-mesothelioma-48609https://curecurrent.com/trials/navelbine-and-radiotherapy-in-locally-advanced-lung-cancer-48610https://curecurrent.com/trials/clinical-characteristics-and-outcomes-of-pediatric-covid-19-48611https://curecurrent.com/trials/lung-cancer-next-generation-sequencing-using-the-oncomine-comprehensive-assay-48612https://curecurrent.com/trials/bpi-7711-capsule-in-patients-with-egfr-mutation-t790m-positive-non-small-cell-lung-cancer-48613https://curecurrent.com/trials/the-prediction-biomarkers-of-survival-outcome-for-severe-immune-related-hepatitis-48614https://curecurrent.com/trials/isatuximab-in-combination-with-regn2810-cemiplimab-in-patients-with-advanced-malignancies-48615https://curecurrent.com/trials/study-of-xl647-in-subjects-with-non-small-cell-lung-cancer-48616https://curecurrent.com/trials/kd019-versus-erlotinib-in-subjects-with-stage-iiib-iv-non-small-cell-lung-cancer-with-progression-after-first-or-second-48617https://curecurrent.com/trials/dose-individualization-of-pemetrexed-improve-ii-48618https://curecurrent.com/trials/continuous-observation-of-smoking-subject-48619https://curecurrent.com/trials/study-of-xl647-in-subjects-with-nsclc-who-have-progressed-after-responding-to-treatment-with-gefitinib-or-erlotinib-48620https://curecurrent.com/trials/biodistribution-and-kinetics-of-18f-arag-in-non-small-cell-lung-cancer-48621https://curecurrent.com/trials/medication-adherence-and-non-adherence-in-adults-with-rare-disease-48622https://curecurrent.com/trials/fasting-mimicking-diet-with-chemo-immunotherapy-in-non-small-cell-lung-cancer-nsclc-48623https://curecurrent.com/trials/study-of-zkab001-combined-with-carboplatin-and-etoposide-in-the-extensive-small-cell-lung-cancer-48624https://curecurrent.com/trials/erector-spinae-plane-block-versus-paravertebral-block-during-non-intubated-thoracoscopic-lung-resections-48625https://curecurrent.com/trials/microbiome-in-lung-cancer-and-other-malignancies-48626https://curecurrent.com/trials/value-of-additional-upfront-systematic-lung-ultrasound-in-the-workup-of-patients-with-unilateral-pleural-effusion-48627https://curecurrent.com/trials/feasibility-of-a-smart-device-application-for-home-based-prehabilitation-48628https://curecurrent.com/trials/dose-individualization-of-pemetrexed-improve-iii-48629https://curecurrent.com/trials/nsclc-isotoxic-hypofractionated-radiotherapy-48630https://curecurrent.com/trials/flt-pet-for-early-detection-of-relapse-in-patients-with-irradiated-lung-cancer-48631https://curecurrent.com/trials/nsclc-isotoxic-hypofractionated-chemoradiotherapy-48632https://curecurrent.com/trials/vats-vs-open-thoracic-surgery-for-stage-ii-iii-lung-cancer-48633https://curecurrent.com/trials/patient-forward-access-to-clinical-and-technological-research-genetic-influences-on-cancer-and-atopic-dermatitis-48634https://curecurrent.com/trials/metabolomic-analysis-of-lung-cancer-48635https://curecurrent.com/trials/flt-pet-dw-mri-for-detection-of-brain-metastases-and-early-therapy-evaluation-in-patients-with-small-cell-lung-cancer-48636https://curecurrent.com/trials/a-study-of-hlx07-hlx10-with-or-without-chemotherapy-versus-hlx10-with-chemotherapy-in-first-line-sqnsclc-48637https://curecurrent.com/trials/radiomic-assessment-in-nsclc-correlation-between-multiparametric-imaging-biomarkers-and-genetic-biomarkers-48638https://curecurrent.com/trials/evaluation-of-the-effect-of-different-doses-dexmedetomidine-infusion-on-lung-mechanics-and-oxygenation-in-obese-patients-48639https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-dcvac-luca-immunotherapy-of-lung-cancer-in-patients-with-metastatic-lung-cancer-48640https://curecurrent.com/trials/sbrt-treatment-for-lung-metastasis-from-soft-tissue-sarcoma-48641https://curecurrent.com/trials/a-clinical-study-of-immunotherapy-combined-with-chemotherapy-and-anti-angiogenic-therapy-in-operable-nsclc-48642https://curecurrent.com/trials/a-window-of-opportunity-study-for-investigating-drug-tolerant-persister-dtp-to-preoperative-brigatinib-in-resectable-non-48643https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-hlx07-combination-therapy-in-patients-with-extensive-small-cell-48644https://curecurrent.com/trials/first-line-treatment-of-a-comparison-of-2-treatments-in-elderly-patients-with-advanced-nsclc-48645https://curecurrent.com/trials/cone-beam-ct-guided-robotic-navigational-bronchoscopy-48646https://curecurrent.com/trials/post-market-study-to-collect-data-for-software-recognizing-the-anatomical-structures-during-bronchoscopy-48647https://curecurrent.com/trials/sbrt-ldrt-in-combination-with-camrelizumab-and-apatinib-in-metastatic-non-small-cell-lung-cancer-patient-previously-trea-48648https://curecurrent.com/trials/vx15-2503-in-combination-with-avelumab-in-advanced-non-small-cell-lung-cancer-48649https://curecurrent.com/trials/the-efficacy-and-safety-of-radiotherapy-plus-niraparib-and-toripalimab-in-patients-with-recurrent-small-cell-lung-cancer-48650https://curecurrent.com/trials/clinical-efficacy-and-safety-of-nkt-cell-infusion-in-patients-with-advanced-solid-tumor-48651https://curecurrent.com/trials/a-study-of-es101-pd-l1x4-1bb-bispecific-antibody-in-patients-with-advanced-malignant-thoracic-tumors-48652https://curecurrent.com/trials/correlation-of-metabolic-imaging-with-immune-markers-in-nsclc-candidate-to-immunotherapy-48653https://curecurrent.com/trials/wx-0593-combined-with-concurrent-chemoradiotherapy-in-unresectable-locally-advanced-nsclc-48654https://curecurrent.com/trials/exploring-robotic-assisted-thoracic-surgery-for-lung-cancer-48655https://curecurrent.com/trials/evaluate-the-impact-of-afatinib-on-quality-of-life-and-symptom-burden-of-greek-subjects-with-advanced-nsclc-in-routine-p-48656https://curecurrent.com/trials/the-impact-of-the-covid-19-pandemic-on-testicular-cancer-48657https://curecurrent.com/trials/ofa-in-thoracic-surgery-48658https://curecurrent.com/trials/a-study-of-tqb2450-injection-plus-chemotherapy-followed-by-tqb2450-plus-anlotinib-versus-tislelizumab-plus-chemotherapy-48659https://curecurrent.com/trials/obstructive-sleep-apnea-influences-efficacy-of-pd-1-based-immunotherapy-against-non-small-cell-lung-cancer-48660https://curecurrent.com/trials/comparison-of-two-techniques-of-uniportal-vats-lobectomies-for-clinical-stage-i-non-small-cell-lung-cancer-48661https://curecurrent.com/trials/novel-approach-to-radiotherapy-in-locally-advanced-lung-cancer-concomitant-navelbine-48662https://curecurrent.com/trials/diagnostic-significance-of-single-center-open-and-prospective-evaluation-of-sup-18-sup-f-fdg-pet-ct-dynamic-imaging-and-48663https://curecurrent.com/trials/study-of-ox40-agonist-pf-04518600-alone-and-in-combination-with-4-1bb-agonist-pf-05082566-48664https://curecurrent.com/trials/viewpoints-on-the-social-representations-and-rationale-concerning-the-choices-of-patients-doctors-and-caregivers-with-re-48665https://curecurrent.com/trials/io102-with-pembrolizumab-with-or-without-chemotherapy-as-first-line-treatment-of-metastatic-nsclc-48666https://curecurrent.com/trials/lazertinib-in-patients-with-nsclc-with-asymptomatic-or-mild-symptomatic-brain-metastases-after-failure-of-egfr-tki-48667https://curecurrent.com/trials/breath-combined-with-ct-for-diagnoses-of-pulmonary-nodules-48668https://curecurrent.com/trials/detecting-lung-cancer-based-on-exhaled-breath-48669https://curecurrent.com/trials/the-effect-of-music-on-pain-and-anxiety-in-patients-receiving-chemotherapy-during-covid-19-48670https://curecurrent.com/trials/safety-tolerability-immunogenicity-and-antitumor-activity-of-gen-009-adjuvanted-vaccine-48671https://curecurrent.com/trials/examination-of-exercise-adherence-i-n-lung-cancer-patients-given-calisthenic-exercise-48672https://curecurrent.com/trials/safety-and-immunogenicity-of-prime-boost-vaccination-of-sars-cov-2-in-patients-with-cancer-48673https://curecurrent.com/trials/study-of-carboplatin-plus-etoposide-with-or-without-shr-1316-in-participants-with-untreated-extensive-stage-es-small-cel-48674https://curecurrent.com/trials/sleep-disorders-in-patients-with-suspected-lung-cancer-before-and-after-thoracic-surgery-48675https://curecurrent.com/trials/sars-cov-2-specific-immune-response-after-covid-19-vaccination-in-cancer-patients-48676https://curecurrent.com/trials/cachexia-in-nsclc-patients-diagnosis-characterization-prognosis-functional-and-skeletal-muscle-implications-48677https://curecurrent.com/trials/a-phase-1-2-study-of-bpi-361175-in-subjects-with-advanced-solid-tumors-48678https://curecurrent.com/trials/complications-after-endosonography-and-guided-bronchoscopy-48679https://curecurrent.com/trials/a-clinical-test-for-the-treatment-of-multifocal-lung-cancers-using-genome-sequencing-48680https://curecurrent.com/trials/afatinib-and-necitumumab-in-patients-with-egfr-mutation-positive-advanced-or-metastatic-non-small-cell-lung-cancer-48681https://curecurrent.com/trials/pd-l1-inhibitor-rechallenge-after-pd-1-immunotherapy-for-patients-with-solid-tumor-beyond-lung-cancer-48682https://curecurrent.com/trials/personalizing-the-approach-to-the-oncologic-frail-individual-through-tailored-assessment-and-intervention-profit-study-48683https://curecurrent.com/trials/preoperative-exercise-for-patients-undergoing-complex-cancer-surgery-48684https://curecurrent.com/trials/a-study-of-bbi608-in-combination-with-pemetrexed-and-cisplatin-in-adult-patients-with-malignant-pleural-mesothelioma-48685https://curecurrent.com/trials/evaluating-the-safety-and-feasibility-of-tld-for-the-treatment-of-severe-asthma-48686https://curecurrent.com/trials/pharmacogenomic-study-for-providing-personalized-strategy-to-the-treatment-of-non-small-cell-lung-cancer-nsclc-iiib-iv-48687https://curecurrent.com/trials/amrubicin-amr-trial-in-patients-with-non-small-cell-lung-cancer-48688https://curecurrent.com/trials/a-study-of-paclitaxel-carboplatin-with-or-without-cdp791-in-patients-with-lung-cancer-48689https://curecurrent.com/trials/amrubicin-study-for-elderly-patients-with-extensive-disease-small-cell-lung-cancer-ed-sclc-48690https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-pd-l1-positive-50-of-tumor-cells-advanced-nscl-cancer-pembreizh-48691https://curecurrent.com/trials/pulmonary-rehab-l-tat-on-w-th-non-small-lung-cancer-48692https://curecurrent.com/trials/study-of-the-kinetics-of-antibodies-against-covid-19-sars-cov-2-and-of-cellular-subpopulations-of-the-immune-system-48693https://curecurrent.com/trials/a-phase-i-study-of-tq-b3456-on-tolerance-and-pharmacokinetics-48694https://curecurrent.com/trials/dual-sstr2-and-integrin-v-3-targeting-pet-ct-imaging-48695https://curecurrent.com/trials/osimertinib-for-russian-egfr-t790m-mutation-positive-nsclc-patients-who-progressed-on-or-after-egfr-tki-therapy-48696https://curecurrent.com/trials/neoadjuvant-erlotinib-for-operable-stage-ii-or-iiia-nsclc-with-egfr-mutations-48697https://curecurrent.com/trials/a-study-of-tarceva-vs-avastin-tarceva-for-advanced-nsclc-with-egfr-m-48698https://curecurrent.com/trials/nivolumab-after-cyclophosphamide-and-doxorubicin-induction-therapy-in-nsclc-with-pd-l1-10-48699https://curecurrent.com/trials/neoadjuvant-therapy-of-pembrolizumab-ramucirumab-for-pd-l1-positive-stage-ib-iiia-lung-cancer-east-energy-48700https://curecurrent.com/trials/immunotherapy-combination-study-in-advanced-previously-treated-non-small-cell-lung-cancer-48701https://curecurrent.com/trials/effect-of-exercise-training-in-lung-cancer-48702https://curecurrent.com/trials/irinotecan-cisplatin-with-or-without-simvastatin-in-chemo-naive-patients-with-extensive-disease-small-cell-lung-cancer-48703https://curecurrent.com/trials/bibw-2992-plus-simvastatin-vs-bibw-2992-in-previously-treated-patients-with-advanced-non-adenocarcinomatous-nsclc-48704https://curecurrent.com/trials/study-of-lorlatinib-in-ros1-rearranged-nsclc-48705https://curecurrent.com/trials/sequential-hypofractionated-radiotherapy-followed-by-anti-pd-l1-atezolizumab-for-sclc-48706https://curecurrent.com/trials/phase-1-2a-dose-escalation-study-in-participants-with-cll-sll-or-nhl-48707https://curecurrent.com/trials/sapanisertib-in-treating-patients-with-stage-iv-or-recurrent-lung-cancer-48708https://curecurrent.com/trials/comparison-of-segmentectomy-versus-lobectomy-for-non-small-cell-lung-cancer-2-cm-in-the-middle-third-of-the-lung-field-48709https://curecurrent.com/trials/continuous-24h-intravenous-infusion-of-mithramycin-an-inhibitor-of-cancer-stem-cell-signaling-in-people-with-primary-tho-48710https://curecurrent.com/trials/study-of-selective-braf-kinase-inhibitor-dabrafenib-monotherapy-twice-daily-and-in-combination-with-dabrafenib-twice-dai-48711https://curecurrent.com/trials/to-investigate-the-use-of-a-new-syringe-visual-pressure-control-vpc-for-epidural-anesthesia-in-children-surgery-48712https://curecurrent.com/trials/medi4736-anti-pd-l1-combined-with-gefitinib-in-subjects-with-non-small-cell-lung-cancer-nsclc-48713https://curecurrent.com/trials/bronchoscopy-assisted-by-electromagnetic-navigation-emn-in-the-diagnosis-of-small-pulmonary-nodules-48714https://curecurrent.com/trials/sintilimab-combined-with-anlotinib-therapy-for-initially-unresectable-non-small-cell-lung-cancer-48715https://curecurrent.com/trials/study-of-an-immunotherapeutic-dpx-survivac-in-combination-with-low-dose-cyclophosphamide-pembrolizumab-in-subjects-with-48716https://curecurrent.com/trials/a-study-of-tqb2450-in-subjects-with-stage-iii-non-small-cell-lung-cancer-nsclc-48717https://curecurrent.com/trials/the-study-for-evaluating-the-clinical-effectiveness-and-safety-of-respiratory-rehabilitation-software-redpill-breath-cop-48718https://curecurrent.com/trials/utility-of-ldct-in-lung-cancer-screening-in-a-tb-endemic-region-48719https://curecurrent.com/trials/study-of-pembrolizumab-with-single-agent-chemotherapy-in-elderly-patients-with-advanced-nsclc-48720https://curecurrent.com/trials/ultra-low-doses-of-therapy-with-radiation-applicated-to-covid-19-48721https://curecurrent.com/trials/utidelone-in-third-line-and-above-treatment-of-small-cell-lung-cancer-48722https://curecurrent.com/trials/folic-acid-interferes-with-radiation-esophagitis-48723https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-xav-19-in-patients-with-covid-19-induced-moderate-pneumonia-48724https://curecurrent.com/trials/a-study-to-evaluate-the-combination-of-nivolumab-with-adg106-in-metastatic-nsclc-48725https://curecurrent.com/trials/an-investigational-immuno-therapy-study-of-nivolumab-given-after-surgery-in-non-small-cell-lung-cancer-nsclc-participant-48726https://curecurrent.com/trials/proton-therapy-for-stage-i-non-small-cell-lung-cancer-lu03-48727https://curecurrent.com/trials/rivaroxaban-utilization-for-treatment-and-prevention-of-thromboembolism-in-cancer-patients-experience-at-a-comprehensive-48728https://curecurrent.com/trials/gefitinib-long-term-survivor-study-48729https://curecurrent.com/trials/central-malignant-airway-obstructions-medical-treatment-alone-versus-endoscopic-and-medical-treatmen-48730https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-in-locally-advanced-non-small-cell-lung-cancer-48731https://curecurrent.com/trials/expiratory-muscle-training-versus-incentive-spirometry-after-colorectal-surgery-48732https://curecurrent.com/trials/preoperative-lymph-node-staging-with-ebus-tbna-in-clinical-n0-non-small-cell-lung-cancer-48733https://curecurrent.com/trials/human-il-15-rhil-15-and-obinutuzumab-for-relapsed-and-refractory-chronic-lymphocyte-leukemia-48734https://curecurrent.com/trials/a-study-of-atezolizumab-in-combination-with-carboplatin-paclitaxel-or-carboplatin-nab-paclitaxel-compared-with-carboplat-48735https://curecurrent.com/trials/a-single-arm-phase-ii-clinical-study-of-pemigatinib-in-the-treatment-of-advanced-non-small-cell-lung-cancer-patients-wit-48736https://curecurrent.com/trials/a-safety-and-feasibility-study-of-ags-003-lng-for-the-treatment-of-stage-3-non-small-cell-lung-cancer-48737https://curecurrent.com/trials/effect-of-pulmonary-rehabilitation-in-lung-cancer-survivors-48738https://curecurrent.com/trials/trial-of-either-surgery-or-stereotactic-radiotherapy-for-early-stage-ia-lung-cancer-48739https://curecurrent.com/trials/tq-b3525-tablets-combined-with-osimertinib-mesylate-tablets-in-the-treatment-of-advanced-non-small-cell-lung-cancer-48740https://curecurrent.com/trials/mrd-monitoring-in-lung-cancer-after-resection-48741https://curecurrent.com/trials/head-and-neck-cancers-international-covid-19-collaboration-48742https://curecurrent.com/trials/ethaselen-for-the-treatment-of-thioredoxin-reductase-high-expression-advanced-non-small-cell-lung-cancers-48743https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-ilixadencel-administered-into-tumors-in-combination-with-checkpoint-48744https://curecurrent.com/trials/tki-discontinuation-in-cml-patients-of-china-48745https://curecurrent.com/trials/phase-2-study-of-study-of-tesevatinib-in-subjects-with-nsclc-and-brain-or-leptomeningeal-metastases-48746https://curecurrent.com/trials/myl-1402o-compared-with-avastin-in-patients-with-stage-iv-nsnsclc-48747https://curecurrent.com/trials/national-lung-cancer-registry-in-men-and-women-based-on-diagnosis-in-algeria-48748https://curecurrent.com/trials/the-effect-of-interventional-pulmonary-rehabilitation-exercise-with-advanced-lung-cancer-48749https://curecurrent.com/trials/trial-of-bi-shrna-furin-and-gmcsf-augmented-autologous-tumor-cell-vaccine-for-advanced-cancer-48750https://curecurrent.com/trials/decamp-1-diagnosis-and-surveillance-of-indeterminate-pulmonary-nodules-48751https://curecurrent.com/trials/pirfenidone-combined-with-methylprednisolone-versus-methylprednisolone-in-the-treatment-of-cip-48752https://curecurrent.com/trials/a-study-of-capmatinib-inc280-in-nsclc-patients-with-met-exon-14-alterations-who-have-received-prior-met-inhibitor-48753https://curecurrent.com/trials/independent-predictors-analysis-and-model-construction-of-cavitary-central-lung-cancer-48754https://curecurrent.com/trials/neo-adjuvant-treatment-in-non-small-cell-lung-cancer-nsclc-48755https://curecurrent.com/trials/evaluation-of-fkb238-and-avastin-in-patients-with-advanced-recurrent-non-squamous-non-small-cell-lung-cancer-48756https://curecurrent.com/trials/immunicell-in-patients-with-advanced-cancers-48757https://curecurrent.com/trials/sorafenib-erlotinib-versus-erlotinib-alone-in-previously-treated-advanced-non-small-cell-lung-cancer-nsclc-48758https://curecurrent.com/trials/study-of-cabiralizumab-in-combination-with-nivolumab-in-patients-with-selected-advanced-cancers-48759https://curecurrent.com/trials/safety-and-efficacy-of-ingenol-mebutate-gel-0-015-for-treatment-of-ak-on-the-face-in-solid-organ-transplant-recipients-48760https://curecurrent.com/trials/pet-scan-and-ct-scan-in-evaluating-response-in-patients-undergoing-radiofrequency-ablation-for-lung-metastases-48761https://curecurrent.com/trials/lung-cancer-focus-long-term-monitoring-of-bronchogenic-carcinoma-patients-lucas-48762https://curecurrent.com/trials/immunopheresis-alone-or-in-combination-with-paclitaxel-or-atezolizumab-in-non-small-cell-lung-cancer-nsclc-48763https://curecurrent.com/trials/fdg-fluorodeoxyglucose-findings-after-covid-19-vaccination-48764https://curecurrent.com/trials/study-of-sbrt-efficacy-on-intra-and-extra-cranial-tumors-or-metastasis-in-pediatrics-population-sbrt-pediatrics-48765https://curecurrent.com/trials/gefitinib-with-or-without-chemotherapy-in-brain-metastases-from-non-small-cell-lung-cancer-48766https://curecurrent.com/trials/a-study-to-evaluate-the-value-of-circulating-tumour-dna-in-follow-up-of-patients-with-an-advanced-gastroenteropancreatic-48767https://curecurrent.com/trials/prognostic-value-of-the-6-minute-stepper-test-in-non-small-cell-lung-cancer-surgery-48768https://curecurrent.com/trials/pembrolizumab-with-or-without-chemotherapy-before-surgery-in-treating-patients-with-stage-i-iiia-non-small-cell-lung-can-48769https://curecurrent.com/trials/a-phase-1-study-of-kbp-5209-in-patients-with-advanced-solid-tumors-48770https://curecurrent.com/trials/neoadjuvant-immunotherapy-with-durvalumab-medi4736-in-non-surgical-early-stage-or-locally-advanced-non-small-cell-lung-c-48771https://curecurrent.com/trials/improving-implementation-of-lung-cancer-screening-in-diverse-populations-ii-48772https://curecurrent.com/trials/breathe-anew-for-lung-cancer-survivorship-48773https://curecurrent.com/trials/preoperative-therapy-in-patients-with-stages-ib-ii-iiia-and-selected-iiib-patients-with-non-small-cell-lung-cancer-48774https://curecurrent.com/trials/study-of-durvalumab-or-durvalumab-plus-chemotherapy-in-kras-mutation-positive-and-pd-l1-high-50-nsclc-patients-48775https://curecurrent.com/trials/early-access-program-of-lazertinib-in-republic-of-korea-48776https://curecurrent.com/trials/pemetrexed-and-gemcitabine-in-patients-with-advanced-non-small-cell-lung-cancer-48777https://curecurrent.com/trials/mortality-of-cancer-surgery-during-sars-cov2-pandemic-48778https://curecurrent.com/trials/tusc2-nanoparticles-and-erlotinib-in-stage-iv-lung-cancer-48779https://curecurrent.com/trials/phase-ii-study-on-sintilimab-combined-with-docetaxel-for-chemotherapy-failure-advanced-nsclc-the-success-study-48780https://curecurrent.com/trials/sintilimab-combined-with-docetaxel-for-standard-chemotherapy-failure-non-driver-gene-mutation-metastatic-non-small-cell-48781https://curecurrent.com/trials/fruquintinib-combined-with-sintilimab-and-chemotherapy-in-the-treatment-of-non-small-cell-lung-cancer-48782https://curecurrent.com/trials/appropriate-dosing-to-optimise-personalised-cancer-treatments-48783https://curecurrent.com/trials/study-of-efficacy-and-safety-of-nivolumab-in-combination-with-egf816-and-of-nivolumab-in-combination-with-inc280-in-pati-48784https://curecurrent.com/trials/a-study-of-epacadostat-and-nivolumab-in-combination-with-immune-therapies-in-participants-with-advanced-or-metastatic-ma-48785https://curecurrent.com/trials/effects-of-covid-19-pandemic-on-the-outcomes-of-colorectal-cancer-48786https://curecurrent.com/trials/a-prospective-multi-center-phase-iii-randomized-controlled-trial-48787https://curecurrent.com/trials/azd2811-and-durvalumab-medi4736-combination-therapy-in-relapsed-small-cell-lung-cancer-48788https://curecurrent.com/trials/prospective-determination-of-covid-19-infection-rate-in-a-chemotherapy-unit-in-mexico-48789https://curecurrent.com/trials/a-trial-of-anlotinib-combined-with-concurrent-chemoradiotherapy-in-patients-with-unresectable-stage-iii-non-small-cell-l-48790https://curecurrent.com/trials/efficacy-and-safety-of-almonertinib-combined-with-or-without-chemotherapy-as-an-adjuvant-treatment-for-stage-ii-iiia-non-48791https://curecurrent.com/trials/neoadjuvant-durvalumab-alone-or-in-combination-with-novel-agents-in-resectable-non-small-cell-lung-cancer-48792https://curecurrent.com/trials/artificial-intelligence-for-help-non-small-cell-lung-cancer-measure-cancer-biology-and-treatment-response-via-imaging-48793https://curecurrent.com/trials/long-term-epidemiological-follow-up-of-non-small-cell-lung-cancer-in-scandinavia-48794https://curecurrent.com/trials/cardiac-substructure-radiation-dose-and-early-clinical-monitoring-of-stage-n2-3-non-small-cell-lung-cancer-48795https://curecurrent.com/trials/an-exploratory-study-of-herombopag-for-thrombocytopenia-induced-by-chemotherapy-combined-with-immunotherapy-in-nsclc-48796https://curecurrent.com/trials/prospective-sampling-in-driver-mutation-pulmonary-oncology-patients-on-tyrosine-kinase-inhibitors-start-tki-48797https://curecurrent.com/trials/brigatinib-in-treating-patients-with-alk-and-ros1-gene-alterations-and-locally-advanced-or-metastatic-solid-cancers-48798https://curecurrent.com/trials/a-open-label-post-marketing-surveillance-study-following-transfusion-of-intercept-platelet-components-48799https://curecurrent.com/trials/an-open-label-multicenter-phase-2-study-of-durvalumab-medi4736-olaparib-as-maintenance-therapy-in-chinese-48800https://curecurrent.com/trials/comparison-of-robotic-arm-assisted-pet-ct-guided-lung-biopsy-with-pet-fused-ct-fluoroscopy-guided-lung-biopsy-48801https://curecurrent.com/trials/envafolimab-combined-with-chemotherapy-and-recombinant-human-endostatin-in-the-first-line-treatment-of-sq-nsclc-48802https://curecurrent.com/trials/development-and-pilot-testing-of-a-clinical-informatics-lung-cancer-screening-intervention-48803https://curecurrent.com/trials/pen-866-in-patients-with-advanced-solid-malignancies-48804https://curecurrent.com/trials/association-between-proton-pump-inhibitors-and-hematologic-toxicity-of-pemetrexed-48805https://curecurrent.com/trials/the-use-and-effectiveness-of-balloon-for-endobronchial-ultrasonography-48806https://curecurrent.com/trials/functional-imaging-of-treatment-effects-a-companion-protocol-to-a-study-of-extracranial-stereotactic-radioablation-in-ea-48807https://curecurrent.com/trials/evaluating-crizotinib-in-the-neoadjuvant-setting-in-patients-with-non-small-cell-lung-cancer-48808https://curecurrent.com/trials/study-of-ponatinib-in-patients-with-lung-cancer-preselected-using-different-candidate-predictive-biomarkers-48809https://curecurrent.com/trials/generation-of-a-lung-biobank-for-future-use-48810https://curecurrent.com/trials/sabr-for-t1-2a-n1-nsclc-48811https://curecurrent.com/trials/pharmacokinetic-and-safety-study-of-lower-doses-of-ceritinib-taken-with-a-low-fat-meal-versus-750-mg-of-ceritinib-in-the-48812https://curecurrent.com/trials/a-clinical-study-of-lung-ct-cad-decision-support-48813https://curecurrent.com/trials/charcoal-in-lung-cancer-patients-undergoing-temla-48814https://curecurrent.com/trials/glypican-1-expression-in-epithelioid-mesothelioma-adenocarcinoma-and-scc-of-the-lung-48815https://curecurrent.com/trials/influence-factors-of-pd-1-therapeutic-efficacy-in-advanced-pancreatic-cancer-48816https://curecurrent.com/trials/pemetrexed-and-or-sunitinib-as-second-line-therapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-48817https://curecurrent.com/trials/impact-of-covid-19-after-autologous-hematopoietic-stem-cell-transplantation-in-sweden-48818https://curecurrent.com/trials/liquid-biopsy-using-methylation-sequencing-for-lung-cancer-48819https://curecurrent.com/trials/safety-study-of-enoblituzumab-mga271-in-combination-with-ipilimumab-in-refractory-cancer-48820https://curecurrent.com/trials/impact-of-pharmacist-led-educational-intervention-on-pneumococcal-vaccination-rates-in-cancer-patients-48821https://curecurrent.com/trials/icotinib-as-an-adjuvant-therapy-for-patients-with-stage-iia-iiia-adenocarcinoma-with-egfr-mutation-48822https://curecurrent.com/trials/pharmacokinetically-guided-on-the-individualization-of-pembrolizumab-administration-in-the-treatment-of-lung-cancer-48823https://curecurrent.com/trials/neoadjuvant-immunotherapy-in-advanced-nsclc-48824https://curecurrent.com/trials/study-of-olaparib-and-temozolomide-in-patients-with-recurrent-small-cell-lung-cancer-following-failure-of-prior-chemothe-48825https://curecurrent.com/trials/using-connected-health-to-increase-lung-cancer-screening-48826https://curecurrent.com/trials/effect-of-muscle-and-skin-fixation-of-thoracic-drainage-tube-on-postoperative-pain-48827https://curecurrent.com/trials/hiv-indicator-diseases-in-hospital-and-primary-care-48828https://curecurrent.com/trials/development-of-an-evaluation-method-of-elderly-condition-in-patient-receiving-chemotherapy-treatment-48829https://curecurrent.com/trials/a-study-of-gentuximab-in-combination-with-almonertinib-in-egfr-mutation-positive-metastatic-nsclc-48830https://curecurrent.com/trials/evaluation-of-the-clinical-biological-characteristics-efficacy-and-safety-of-patients-with-malignant-pleural-mesotheliom-48831https://curecurrent.com/trials/effect-of-the-minimum-bronchial-cuff-volume-of-left-sided-double-lumen-endotracheal-tube-for-one-lung-ventilation-on-the-48832https://curecurrent.com/trials/combination-chemotherapy-surgery-and-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-48833https://curecurrent.com/trials/pathological-classification-of-pulmonary-nodules-in-images-using-deep-learning-48834https://curecurrent.com/trials/a-retrospective-study-of-the-effectiveness-and-safety-of-nivolumab-in-advanced-metastatic-non-small-cell-lung-cancer-nsc-48835https://curecurrent.com/trials/impact-on-quality-of-life-from-multi-modality-lung-cancer-48836https://curecurrent.com/trials/immune-response-to-third-dose-of-sars-cov-2-vaccine-in-a-cohort-of-cancer-patients-on-active-treatment-48837https://curecurrent.com/trials/exosomes-detection-for-the-prediction-of-the-efficacy-and-adverse-reactions-of-anlotinib-in-patients-with-advanced-nsclc-48838https://curecurrent.com/trials/18f-arag-for-the-detection-of-t-cell-activation-in-advanced-non-small-cell-lung-cancer-patients-undergoing-pd-1-pd-l1-di-48839https://curecurrent.com/trials/exploration-of-the-volatolom-in-the-stable-severe-copd-chronic-obstructive-pulmonary-disease-48840https://curecurrent.com/trials/a-single-arm-clinical-study-of-pemigatinib-in-the-treatment-of-advanced-non-small-cell-lung-cancer-patients-48841https://curecurrent.com/trials/volatile-organic-compounds-in-exhaled-air-and-sweat-of-patients-treated-by-immunotherapy-for-lung-cancer-research-on-bio-48842https://curecurrent.com/trials/alflutinib-versus-alflutinib-plus-chemotherapy-for-nsclc-48843https://curecurrent.com/trials/adjuvant-tumor-lysate-vaccine-and-iscomatrix-with-or-without-metronomic-oral-cyclophosphamide-and-celecoxib-in-patients-48844https://curecurrent.com/trials/treatment-patterns-in-advanced-small-cell-lung-cancer-sclc-48845https://curecurrent.com/trials/tislelizumab-plus-chemotherapy-as-first-line-treatment-for-advanced-squamous-nsclc-with-brain-metastases-48846https://curecurrent.com/trials/first-in-human-study-of-s-588210-s-488210-s-488211-48847https://curecurrent.com/trials/efficacy-and-safety-of-immunotherapy-in-non-small-cell-lung-cancer-with-uncommon-histological-type-48848https://curecurrent.com/trials/efficacy-biomarker-investigation-on-extensive-stage-small-cell-lung-cancer-48849https://curecurrent.com/trials/tumor-microenvironment-surveillance-on-simultaneous-liver-metastases-extensive-stage-small-cell-lung-cancer-48850https://curecurrent.com/trials/local-radiotherapy-for-residual-tumor-lesions-during-the-first-line-treatment-48851https://curecurrent.com/trials/emotional-and-physical-health-status-of-adults-48852https://curecurrent.com/trials/a-study-to-evaluate-and-compare-the-efficacy-and-safety-of-xzp-3621-versus-crizotinib-48853https://curecurrent.com/trials/a-study-of-pembrolizumab-plus-epacadostat-with-platinum-based-chemotherapy-versus-pembrolizumab-plus-platinum-based-chem-48854https://curecurrent.com/trials/study-of-capmatinib-and-spartalizumab-combination-therapy-vs-docetaxel-in-non-small-cell-lung-cancer-48855https://curecurrent.com/trials/hippocampus-avoidance-pci-vs-pci-48856https://curecurrent.com/trials/dose-escalation-by-boosting-radiation-dose-within-the-primary-tumor-using-fdg-pet-ct-scan-in-stage-ib-ii-and-iii-nsclc-48857https://curecurrent.com/trials/a-phase-ii-clinical-trial-to-evaluate-hlx208-in-advanced-non-small-cell-lung-cancer-patients-with-braf-v600-mutation-48858https://curecurrent.com/trials/liver-toxicity-in-lung-cancer-patients-treated-with-immune-checkpoint-inhibitors-48859https://curecurrent.com/trials/ds-1205c-with-osimertinib-for-metastatic-or-unresectable-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lun-48860https://curecurrent.com/trials/adjuvant-targeted-therapy-for-patients-with-resected-high-risk-egfr-mutant-stage-ib-iia-non-small-cell-lung-carcinoma-48861https://curecurrent.com/trials/circulating-ev-long-rna-profiles-in-sclc-48862https://curecurrent.com/trials/effect-of-the-covid-19-public-health-crisis-on-the-mental-health-and-physical-well-being-of-cancer-patients-the-coping-w-48863https://curecurrent.com/trials/tislelizumab-as-cross-line-treatment-for-advanced-nsclc-48864https://curecurrent.com/trials/a-clinical-trial-of-taa06-injection-in-advanced-solid-tumors-48865https://curecurrent.com/trials/a-study-of-epacadostat-incb024360-in-combination-with-durvalumab-medi4736-in-subjects-with-selected-advanced-solid-tumor-48866https://curecurrent.com/trials/trial-of-pbf-509-and-pdr001-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-48867https://curecurrent.com/trials/battle-2-program-a-biomarker-integrated-targeted-therapy-study-in-previously-treated-patients-with-advanced-non-small-ce-48868https://curecurrent.com/trials/fl-101-in-surgically-resectable-non-small-cell-lung-cancer-48869https://curecurrent.com/trials/a-study-in-the-united-states-using-electronic-medical-records-emr-to-assess-effectiveness-of-afatinib-gilotrif-following-48870https://curecurrent.com/trials/impact-of-the-covid-19-pandemic-on-drug-use-and-monitoring-of-cancer-patients-48871https://curecurrent.com/trials/a-study-comparing-ensatinib-versus-platinum-based-chemotherapy-as-adjuvant-treatment-for-stage-ii-iiia-alk-positive-non-48872https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-the-safety-of-first-line-chemotherapy-combined-with-the-therapeutic-vaccine-named-tg-48873https://curecurrent.com/trials/personalized-neo-antigen-vaccine-in-advanced-solid-tumors-neopepvac-48874https://curecurrent.com/trials/first-line-treatment-of-patients-with-stage-iv-nonsquamous-non-small-cell-lung-cancer-with-necitumumab-imc-11f8-and-peme-48875https://curecurrent.com/trials/pd-l1-imaging-in-non-small-cell-lung-cancer-pinnacle-48876https://curecurrent.com/trials/combination-of-durvalumab-and-tremelimumab-as-maintenance-treatment-in-patients-with-non-squamous-and-squamous-nsclc-48877https://curecurrent.com/trials/ensatinib-treat-second-generation-alk-tki-resistance-after-second-generation-alk-tki-resistance-48878https://curecurrent.com/trials/safety-tolerability-and-preliminary-efficacy-of-jk1201i-in-patients-with-sclc-48879https://curecurrent.com/trials/study-of-pembrolizumab-maintenance-following-first-line-platinum-based-chemotherapy-in-patients-with-metastatic-squamous-48880https://curecurrent.com/trials/impact-of-risk-for-osa-in-lung-cancer-48881https://curecurrent.com/trials/shr-1701-for-consolidation-therapy-after-concurrent-chemoradiotherapy-in-inoperable-stage-iii-nsclc-48882https://curecurrent.com/trials/randomized-controlled-clinical-study-of-drug-therapy-combined-with-thoracic-radiotherapy-for-non-oligometastatic-nsclc-48883https://curecurrent.com/trials/safety-and-tolerability-of-emricasan-in-symptomatic-outpatients-diagnosed-with-mild-covid-19-48884https://curecurrent.com/trials/study-of-thymosin-1-to-reduce-acute-pneumonia-for-bulky-none-small-cell-lung-cancer-48885https://curecurrent.com/trials/phase-i-ii-study-of-lenalidomide-plus-pembrolizumab-in-patients-with-solid-tumors-with-expansion-in-non-small-cell-lung-48886https://curecurrent.com/trials/multicenter-clinical-research-for-early-diagnosis-of-lung-cancer-using-blood-plasma-derived-exosome-48887https://curecurrent.com/trials/safety-and-efficacy-study-of-bosutinib-in-patients-with-philadelphia-chromosome-positive-chronic-myeloid-leukemia-previo-48888https://curecurrent.com/trials/persistent-sars-cov-2-infection-in-children-with-cancer-and-impaired-immune-responsiveness-48889https://curecurrent.com/trials/tisotumab-vedotin-humax-tf-adc-safety-study-in-patients-with-solid-tumors-48890https://curecurrent.com/trials/low-dose-computed-tomography-guided-core-needle-biopsy-for-lung-nodules-48891https://curecurrent.com/trials/opioid-free-anaesthesia-analgesia-strategy-on-surgical-stress-and-immunomodulation-in-elective-vats-lobectomy-for-nsclc-48892https://curecurrent.com/trials/genetic-predictors-of-efficiency-and-safety-of-icis-in-patients-with-different-malignancies-icipresist-0519-48893https://curecurrent.com/trials/clinical-study-of-sintilimab-combined-with-chemotherapy-in-neoadjuvant-treatment-of-non-small-cell-lung-cancer-48894https://curecurrent.com/trials/to-compare-the-efficacy-and-safety-of-bp102-vs-avastin-in-combination-with-paclitaxel-carboplatin-in-first-line-treatmen-48895https://curecurrent.com/trials/the-impact-of-covid-19-pandemic-on-clinical-presentation-and-staging-of-gastric-cancer-48896https://curecurrent.com/trials/clinical-and-multiomics-study-of-first-line-chemotherapy-for-advanced-pancreatic-cancer-48897https://curecurrent.com/trials/pharmacokinetics-of-apixaban-in-patients-undergoing-pancreaticoduodenectomy-48898https://curecurrent.com/trials/clinical-value-of-mrd-monitoring-for-adjuvant-therapy-in-postoperative-nsclc-48899https://curecurrent.com/trials/a-study-of-oral-sapacitabine-in-patients-with-previously-treated-non-small-cell-lung-cancer-48900https://curecurrent.com/trials/efficacy-study-of-oral-seliciclib-to-treat-non-small-cell-lung-cancer-48901https://curecurrent.com/trials/the-safety-and-efficacy-of-first-line-lazertinib-and-locally-ablative-radiotherapy-in-patients-with-synchronous-oligo-me-48902https://curecurrent.com/trials/cisplatin-pemetrexed-compared-with-carboplatin-paclitaxel-bevacizumab-in-kras-mutated-non-small-cell-lung-cancer-48903https://curecurrent.com/trials/aerosolized-azacytidine-as-epigenetic-priming-for-bintrafusp-alfa-mediated-immune-checkpoint-blockade-in-patients-with-u-48904https://curecurrent.com/trials/early-diagnosis-and-treatment-of-sleep-disordered-breathing-in-lung-cancer-48905https://curecurrent.com/trials/augmented-reality-assisted-localization-of-solitary-pulmonary-nodules-for-precise-sublobar-lung-resection-48906https://curecurrent.com/trials/impact-of-baduanjin-qigong-exercise-on-fatigue-in-patients-with-nsclc-undergoing-adjuvant-chemotherapy-48907https://curecurrent.com/trials/regorafenib-in-treating-patients-with-advanced-or-metastatic-neuroendocrine-tumors-48908https://curecurrent.com/trials/treatment-of-patients-with-stage-iii-non-small-cell-lung-cancer-in-russia-48909https://curecurrent.com/trials/ixabepilone-and-carboplatin-bevacizumab-in-advanced-non-small-cell-lung-cancer-48910https://curecurrent.com/trials/neoadjuvant-ldrt-combined-with-durvalumab-in-potentially-resectable-stage-iii-nsclc-48911https://curecurrent.com/trials/anti-pd-1-neo-adjuvant-treatment-for-nsclc-48912https://curecurrent.com/trials/pen-221-in-somatostatin-receptor-2-expressing-advanced-cancers-including-neuroendocrine-and-small-cell-lung-cancers-48913https://curecurrent.com/trials/a-dose-escalation-study-of-pf-06801591-in-melanoma-head-and-neck-cancer-scchn-ovarian-sarcoma-non-small-cell-lung-cancer-48914https://curecurrent.com/trials/study-of-hl-085-plus-docetaxel-in-patients-with-kras-mutant-nsclc-48915https://curecurrent.com/trials/anti-androgen-treatment-for-covid-19-48916https://curecurrent.com/trials/neoadjuvant-icotinib-with-chemotherapy-for-epidermal-growth-factor-receptor-egfr-mutated-resectable-lung-adenocarcinoma-48917https://curecurrent.com/trials/respiratory-distress-symptom-intervention-rdsi-trial-48918https://curecurrent.com/trials/phase-i-trial-of-imrt-using-a-contralateral-esophagus-sparing-technique-cest-in-locally-advanced-lung-cancer-48919https://curecurrent.com/trials/screening-for-cancer-in-patients-with-unprovoked-vte-48920https://curecurrent.com/trials/nintedanib-in-treating-patients-with-malignant-pleural-mesothelioma-that-is-recurrent-48921https://curecurrent.com/trials/forceps-biopsy-versus-cryo-biopsy-in-the-diagnosis-of-lung-cancer-48922https://curecurrent.com/trials/feasibility-of-radioisotope-guided-excision-of-mediastinal-lymph-nodes-in-patients-with-non-small-cells-lung-carcinoma-48923https://curecurrent.com/trials/pembrolizumab-lenvatinib-and-chemotherapy-after-tkis-in-nsclc-48924https://curecurrent.com/trials/camrelizumab-plus-apatinib-as-maintenance-therapy-in-extensive-stage-small-cell-lung-cancer-48925https://curecurrent.com/trials/preoperative-chemotherapy-and-bevacizumab-in-patients-with-stage-ib-4-cm-ii-or-select-stage-iii-nsclc-48926https://curecurrent.com/trials/consistency-of-pd-l1-detecting-method-between-e1l3n-and-22c3-monoclonal-antibodies-in-nsclc-patients-48927https://curecurrent.com/trials/a-phase-1-study-of-nivolumab-bms-936558-in-subjects-with-advanced-or-recurrent-malignancies-48928https://curecurrent.com/trials/a-study-of-mrg002-in-the-treatment-of-patients-with-her2-mutated-unresectable-metastatic-non-small-cell-lung-cancer-nscl-48929https://curecurrent.com/trials/a-phase-ii-study-of-hmpl-504-in-lung-sarcomatoid-carcinoma-and-other-non-small-cell-lung-cancer-48930https://curecurrent.com/trials/evaluation-of-the-response-to-tyrosine-kinase-inhibitors-in-localized-non-small-cell-lung-cancer-nsclc-patients-with-egf-48931https://curecurrent.com/trials/xenon-enhanced-ventilation-ct-guided-radiotherapy-for-lung-cancer-treatment-48932https://curecurrent.com/trials/a-study-of-shr-1701-plus-bevacizumab-and-chemotherapy-in-non-small-cell-lung-cancer-48933https://curecurrent.com/trials/a-study-of-ly3499446-in-participants-with-advanced-solid-tumors-with-kras-g12c-mutation-48934https://curecurrent.com/trials/ensatinib-in-alk-positive-patients-undergoing-initial-treatment-for-advanced-non-small-cell-lung-cancer-48935https://curecurrent.com/trials/kn046-in-subjects-with-advanced-squamous-non-small-cell-lung-cancer-48936https://curecurrent.com/trials/efficacy-and-safety-of-jmt101-combined-with-osimertinib-in-patients-with-non-small-cell-lung-cancer-48937https://curecurrent.com/trials/retrospective-observational-multi-center-study-evaluating-the-efficacy-and-tolerance-of-brigatinib-in-the-management-of-48938https://curecurrent.com/trials/serum-exosomal-long-noncoding-rnas-as-potential-biomarkers-for-lung-cancer-diagnosis-48939https://curecurrent.com/trials/irinotecan-carboplatin-and-sunitinib-in-first-line-extensive-stage-small-cell-lung-cancer-48940https://curecurrent.com/trials/tislelizumab-combined-with-chemotherapy-with-or-without-bevacizumab-in-tki-resistant-egfr-mutated-non-squamous-nsclc-48941https://curecurrent.com/trials/progetto-salute-parma-48942https://curecurrent.com/trials/neo-adjuvant-trial-with-azd9291-in-egfrm-stage-iiia-b-nsclc-48943https://curecurrent.com/trials/comprehensive-genomic-analysis-in-tissue-and-blood-samples-from-young-patients-with-lung-cancer-48944https://curecurrent.com/trials/local-anesthesia-versus-combined-local-anesthesia-with-single-dose-analgesia-on-pain-control-during-thoracic-ultrasound-48945https://curecurrent.com/trials/development-of-an-artificial-intelligence-system-for-intelligent-pathological-diagnosis-and-therapeutic-effect-predictio-48946https://curecurrent.com/trials/imaging-based-deep-learning-for-lung-cancer-diagnosis-and-staging-48947https://curecurrent.com/trials/study-of-pembrolizumab-and-chemotherapy-with-or-without-radiation-in-small-cell-lung-cancer-sclc-48948https://curecurrent.com/trials/clinical-evaluation-of-asp-health-s-automated-rose-system-for-bronchoscopic-applications-48949https://curecurrent.com/trials/auris-robotic-endoscopy-system-for-bronchoscopy-48950https://curecurrent.com/trials/vapor-ablation-for-localized-cancer-lesions-of-the-lung-vaporize-48951https://curecurrent.com/trials/effects-of-buteyko-breathing-technique-versus-incentive-spirometer-on-breath-holding-time-cardiopulmonary-endurance-and-48952https://curecurrent.com/trials/mnsod-esophageal-protectant-to-prevent-esophagitis-during-radiation-chemotherapy-treatment-for-non-small-cell-lung-cance-48953https://curecurrent.com/trials/analysis-of-inflammatory-reactions-observed-in-bronchoalveolar-lavages-bals-48954https://curecurrent.com/trials/real-world-treatment-study-of-azd9291-for-advanced-metastatic-egfr-t790m-mutation-nsclc-48955https://curecurrent.com/trials/safety-and-efficacy-of-chimeric-antigen-receptor-t-lymphocytes-for-patients-with-intermediate-and-advanced-tumors-48956https://curecurrent.com/trials/botulinum-toxin-a-as-treatment-for-chronic-postsurgical-pain-following-lung-cancer-surgery-48957https://curecurrent.com/trials/construction-of-ct-radiomics-model-for-predicting-the-efficacy-of-immunotherapy-in-patients-with-stage-iii-nsclc-48958https://curecurrent.com/trials/chemotherapy-radiotherapy-and-bevacizumab-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-48959https://curecurrent.com/trials/a-study-evaluating-the-safety-tolerability-pharmacokinetics-and-efficacy-of-venetoclax-in-combination-with-atezolizumab-48960https://curecurrent.com/trials/a-study-of-sintilimab-compared-with-docetaxel-or-pemetrexed-as-second-line-treatment-for-patients-with-stage-iv-nonsquam-48961https://curecurrent.com/trials/a-study-of-sintilimab-or-placebo-in-combination-with-chemotherapy-as-second-line-treatment-for-patients-with-stage-iv-no-48962https://curecurrent.com/trials/phase-i-study-of-sph1188-11-in-nsclc-48963https://curecurrent.com/trials/pharmacokinetic-characteristics-safety-tolerability-and-immunogenicity-of-ly01008-and-avastin-in-healthy-chinese-male-su-48964https://curecurrent.com/trials/metabolic-and-microbial-profiling-of-lung-cancer-48965https://curecurrent.com/trials/ramucirumab-atezolizumab-and-n-803-after-progression-on-any-immune-checkpoint-blocker-in-nsclc-48966https://curecurrent.com/trials/pegzilarginase-and-pembrolizumab-for-extensive-disease-small-cell-lung-cancer-48967https://curecurrent.com/trials/a-trial-of-shr-1316-placebo-in-combination-with-chemotherapy-in-patients-with-resectable-nsclc-48968https://curecurrent.com/trials/evaluation-of-computer-aided-lung-nodule-detection-software-in-thoracic-ct-for-riverain-technologies-llc-48969https://curecurrent.com/trials/tisotumab-vedotin-continued-treatment-in-patients-with-solid-tumors-48970https://curecurrent.com/trials/why-in-hospital-after-vats-lobectomy-48971https://curecurrent.com/trials/latest-imaging-spect-system-evaluation-phase-1-48972https://curecurrent.com/trials/a-study-of-icotinib-with-chemotherapy-as-neoadjuvant-therapy-for-patients-with-egfrm-positive-resectable-non-small-cell-48973https://curecurrent.com/trials/incidence-of-mortality-and-complications-after-lung-surgery-open-thoracic-aortic-repair-tevar-evar-48974https://curecurrent.com/trials/effectiveness-of-etanercept-for-idiopathic-pneumonia-syndrome-following-stem-cell-transplantation-bmt-ctn-0403-48975https://curecurrent.com/trials/investigation-of-cannabis-for-pain-and-inflammation-in-lung-cancer-48976https://curecurrent.com/trials/study-of-participants-with-advanced-non-small-cell-lung-cancer-48977https://curecurrent.com/trials/jinfukang-oral-liquid-combined-with-chemotherapy-for-treating-driver-gene-negative-advanced-nsclc-48978https://curecurrent.com/trials/traditional-chinese-medicine-combined-with-thermal-and-cold-ablation-for-early-stage-lung-cancer-48979https://curecurrent.com/trials/clinical-trial-of-lurbinectedin-pm01183-doxorubicin-versus-cav-or-topotecan-as-treatment-in-patients-with-small-cell-lun-48980https://curecurrent.com/trials/nutritional-problems-in-pallative-cancer-48981https://curecurrent.com/trials/phase-i-ii-nabpaclitaxel-paclitaxel-carboplatin-w-rtx-followed-by-consolidation-in-patients-w-favorable-prognosis-inoper-48982https://curecurrent.com/trials/platinum-based-chemotherapy-and-durvalumab-for-the-treatment-of-stage-iiib-or-iv-non-small-cell-lung-cancer-48983https://curecurrent.com/trials/a-study-of-hydroxychloroquine-vs-placebo-to-prevent-covid-19-infection-in-patients-receiving-radiotherapy-48984https://curecurrent.com/trials/lactobacillus-bifidobacterium-v9-kex02-improving-the-efficacy-of-carilizumab-combined-with-platinum-in-non-small-cell-lu-48985https://curecurrent.com/trials/the-impact-of-picture-narrative-format-on-print-lung-screening-communication-outcomes-48986https://curecurrent.com/trials/denosumab-in-combination-with-chemotherapy-as-first-line-treatment-of-metastatic-non-small-cell-lung-cancer-48987https://curecurrent.com/trials/the-role-of-programmed-death-ligand-1-pdl-1-in-lung-cancer-48988https://curecurrent.com/trials/assess-the-use-of-rebus-with-a-guide-sheath-to-increase-transbronchial-lung-biopsy-yield-rate-48989https://curecurrent.com/trials/incentive-spirometry-and-upper-abdominal-laparoscopic-surgery-48990https://curecurrent.com/trials/ucdcc-270-avelumab-and-stereotactic-ablative-radiotherapy-in-non-responding-and-progressing-nsclc-patients-48991https://curecurrent.com/trials/lung-map-s1400k-c-met-positive-48992https://curecurrent.com/trials/relationship-between-circulating-tumor-cell-cultures-treatment-response-and-clinical-outcomes-48993https://curecurrent.com/trials/hippocampal-prophylactic-cranial-irradiation-for-small-cell-lung-cancer-48994https://curecurrent.com/trials/ctdna-mrd-based-adjuvant-targeted-therapy-for-egfr-positive-stage-i-lung-adenocarcinomas-48995https://curecurrent.com/trials/personal-resilience-empowerment-program-study-48996https://curecurrent.com/trials/ultra-low-dose-ct-denoising-for-lung-nodule-detection-48997https://curecurrent.com/trials/a-comparative-study-between-regional-anesthesia-in-thoracoscopes-and-the-conventional-general-anesthesia-48998https://curecurrent.com/trials/inc280-and-erlotinib-hydrochloride-in-treating-patients-with-non-small-cell-lung-cancer-48999https://curecurrent.com/trials/study-of-spi-1620-in-combination-with-docetaxel-versus-docetaxel-alone-for-patients-with-non-small-cell-lung-cancer-nscl-49000